細胞培養市場 – 2030年までの世界予測

本調査レポートでは、細胞培養市場を製品別（機器（バイオリアクター、保管装置、その他）、消耗品（血清、培地、試薬、容器、付属品）、用途別（バイオ医薬品製造（ワクチン製造、モノクローナル抗体製造、その他治療用タンパク質製造）、診断、組織工学・再生医療（細胞・遺伝子治療、その他組織工学・再生医療用途）、薬物スクリーニング・開発、その他用途）、エンドユーザー別（製薬・バイオテクノロジー企業、病院・診断ラボ、研究・学術機関、その他エンドユーザー）、地域別（北米、ヨーロッパ、アジア太平洋、ラテンアメリカ、中東、アフリカ）に分類しています。レポートでは、細胞培養市場の成長に影響を与える主要な要因（推進要因、制約要因、課題、機会など）に関する詳細な情報を網羅しています。主要な業界プレーヤーの詳細な分析により、事業概要、製品、ソリューション、主要戦略、コラボレーション、パートナーシップ、契約。新製品の発売、コラボレーション、そして買収は、細胞培養市場に関連する最近の動向です。

The cell culture market is projected to reach USD 50.69 billion by 2030 from an estimated USD 29.76 billion in 2025, at a CAGR of 11.2% during the forecast period of 2025 to 2030. The growth of this market can be attributed to growing investments and funding for research in the field of cell biology. The rising incidence of chronic diseases such as cancer is boosting the demand for advanced therapies such as tissue engineering and regenerative medicine. This trend is expected to drive the growth of the cell culture market in the coming years.

細胞培養市場は、2025年の推定297億6,000万米ドルから2030年には506億9,000万米ドルに達すると予測されており、2025年から2030年の予測期間中、年平均成長率（CAGR）11.2%で成長します。この市場の成長は、細胞生物学分野への投資と研究資金の増加に起因しています。がんなどの慢性疾患の発生率の上昇は、組織工学や再生医療といった先進的な治療法への需要を押し上げています。この傾向は、今後数年間の細胞培養市場の成長を牽引すると予想されます。

The biopharmaceutical production segment accounted for the largest share of the application segment in 2024.

In 2024, the biopharmaceutical production segment accounted for the largest share of the application segment in the global cell culture market. The biopharmaceutical production segment is further categorized into vaccine production, monoclonal antibody production, and other therapeutic protein production. The growing prevalence of infectious diseases is boosting the demand for biopharmaceuticals such as vaccines, monoclonal antibodies, and therapeutic proteins, which is promoting the growth of biopharmaceutical production in the cell culture market.

The sera, media, and reagents segment accounted for a major share of the consumables market in 2024.

The cell culture consumables market is categorized by type into sera, media, and reagents; vessels; and accessories. The sera, media, and reagents segment accounted for the largest share of the cell culture consumables market in 2024. The large share of this segment is attributed to the repeated bulk purchase and requirement for consumables in the biotechnology and pharmaceutical industries. Research labs and production facilities often require large quantities of sera, media, reagents, vessels, and accessories to sustain continuous cell culture activities. This leads to frequent and substantial procurement for experimentation, testing, and manufacturing processes.

The US dominated the cell culture market in 2024.

In 2024, the cell culture market in North America was led by the US. As the world’s largest biopharmaceutical market with a strong emphasis on research and investment in biopharmaceuticals, the US holds a prominent position. Moreover, the country hosts renowned academic research institutions such as Harvard University, Stanford University, and the Massachusetts Institute of Technology (MIT), renowned for their groundbreaking work in life sciences, including drug discovery and biotechnology, which extensively employ cell culture techniques, thereby fueling market expansion. Furthermore, increasing investments in tissue engineering and regenerative medicine R&D are contributing to the growth of the cell culture market.

The primary interviews conducted for this report can be categorized as follows:

• By Respondent: Supply Side- 70% and Demand Side 30%
• By Designation: Managers – 45%, CXOs & Directors – 30%, and Executives – 25%
• By Region: North America – 40%, Europe -25%, Asia-Pacific -25%, Latin America -5% and Middle East & Africa- 5%

List of Companies Profiled in the Report:

• Thermo Fisher Scientific Inc. (US)
• Danaher Corporation (US)
• Sartorius AG (Germany)
• Merck KGaA (Germany)
• Corning Incorporated (US)
• FUJIFILM Holdings Corporation (Japan)
• BD (US)
• Eppendorf SE (Germany)
• Lonza (Switzerland)
• Getinge AB (Sweden)
• Agilent Technologies, Inc. (US)
• HiMedia Laboratories (India)
• Miltenyi Biotec (Germany)
• STEMCELL Technologies (Canada)
• Solida Biotech GmbH (Germany)
• Caisson Labs (US)
• PromoCell GmbH (Germany)
• InvivoGen (France)
• PAN-Biotech (Germany)
• Cellexus (Scotland)
• Meissner Filtration Products Inc. (US)
• Adolf Kühner AG (Switzerland)
• Bio-Techne (US)
• Advancion Corporation (US)
• BioSpherix, Ltd. (US)

Research Coverage

This research report categorizes the cell culture market by product ((equipment (bioreactors, storage equipment, and other equipment), consumables (sera, media, reagents; vessels, and accessories)), by application (biopharmaceutical production (vaccine production, monoclonal antibody production, and other therapeutic protein production), diagnostics, tissue engineering & regenerative medicine (cell & gene therapy and other tissue engineering & regenerative medicine applications), drug screening & development, and other applications), by end user (pharmaceutical & biotechnology companies, hospitals & diagnostic laboratories, research & academic institutes, and other end users), and by region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the cell culture market. A detailed analysis of the key industry players has been done to provide insights into their business overview, products, solutions, key strategies, collaborations, partnerships, and agreements. New launches, collaborations, and acquisitions are the recent developments associated with the cell culture market.

Key Benefits of Buying the Report

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall cell culture market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market’s pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:

• Analysis of key drivers (increasing prevalence of infectious diseases, rising adoption of single-use technologies, and growing strategic alliances for the development of advanced therapy medicine products), restraints (high cost of cell biology research and limitations regarding production of high density cell culture), opportunities (growing opportunities in emerging economies, rising demand for 3D cell culture), and challenges (ethical concern regarding cell usage) influencing the growth of the market.
• Product Development/Innovation: Detailed insights on newly launched products of the cell culture market
• Market Development: Comprehensive information about lucrative markets – the report analyses the market across varied regions.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the cell culture market
• Competitive Assessment: Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), Sartorius AG (Germany), Merck KGaA (Germany), Corning Incorporated (US), FUJIFILM Holdings Corporation (Japan), BD (US), Eppendorf SE (Germany), Lonza (Switzerland), Getinge AB (Sweden), Agilent Technologies, Inc. (US), HiMedia Laboratories (India), Miltenyi Biotec (Germany), STEMCELL Technologies (Canada), Solida Biotech GmbH (Germany), Caisson Labs (US), PromoCell GmbH (Germany), InvivoGen (France), PAN-Biotech (Germany), Cellexus (Scotland), Meissner Filtration Products Inc. (US), Adolf Kühner AG (Switzerland), Bio-Techne (US), Advancion Corporation (US), and BioSpherix, Ltd. (US)

Table of Contents

1               INTRODUCTION              59

1.1           STUDY OBJECTIVES       59

1.2           MARKET DEFINITION   59

1.3           STUDY SCOPE   59

1.3.1        MARKETS SEGMENTATION AND REGIONAL SCOPE                 60

1.3.2        INCLUSIONS AND EXCLUSIONS 61

1.3.3        YEARS CONSIDERED      62

1.4           CURRENCY CONSIDERED            62

1.5           UNIT CONSIDERED        62

1.6           STAKEHOLDERS               62

1.7           SUMMARY OF CHANGES               63

2               RESEARCH METHODOLOGY       64

2.1           RESEARCH DATA              64

2.1.1        SECONDARY DATA          65

2.1.2        PRIMARY DATA 66

2.2           MARKET ESTIMATION METHODOLOGY               67

2.2.1        GLOBAL MARKET SIZE ESTIMATION, 2024            67

2.2.1.1    Insights from primary sources            70

2.2.2        SEGMENTAL MARKET ESTIMATION        70

2.3           GROWTH RATE PROJECTIONS  71

2.4           DATA TRIANGULATION                74

2.5           RESEARCH ASSUMPTIONS           75

2.6           RESEARCH LIMITATIONS             76

2.7           RISK ANALYSIS  76

3               EXECUTIVE SUMMARY  77

4               PREMIUM INSIGHTS       80

4.1           ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN CELL CULTURE MARKET          80

4.2           NORTH AMERICA: CELL CULTURE MARKET, BY PRODUCT AND COUNTRY           81

4.3           CELL CULTURE MARKET SHARE, BY APPLICATION                 81

4.4           CELL CULTURE MARKET SHARE, BY END USER 82

4.5           CELL CULTURE MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES              82

5               MARKET OVERVIEW       83

5.1           INTRODUCTION              83

5.2           MARKET DYNAMICS       83

5.2.1        DRIVERS               85

5.2.1.1    Increasing support and funding for cell-based research 85

5.2.1.2    Emerging cell culture technologies    87

5.2.1.3    Growing popularity of monoclonal antibodies and biosimilars                 88

5.2.1.4    Increasing adoption of single-use technologies                91

5.2.1.5    Rise in product launches     91

5.2.1.6    Growth in advanced therapy medicinal products            92

5.2.1.7    Increasing incidence of infectious diseases      94

5.2.2        RESTRAINTS      95

5.2.2.1    High cost of cell biology research      95

5.2.2.2    Limitations in producing high-density cell cultures        96

5.2.3        OPPORTUNITIES              96

5.2.3.1    Rising demand for 3D cell culture     96

5.2.3.2    Growth opportunities in emerging economies 98

5.2.3.3    Increasing focus on next-generation therapeutics           99

5.2.4        CHALLENGES    101

5.2.4.1    Disposal of plastic consumables         101

5.2.4.2    Ethical concerns related to cell usage                102

5.3           TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS            102

5.4           PRICING ANALYSIS          104

5.4.1        AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT           105

5.4.2        AVERAGE SELLING PRICE OF PRODUCTS, BY REGION                 105

5.5           VALUE CHAIN ANALYSIS               106

5.6           ECOSYSTEM ANALYSIS  107

5.7           INVESTMENT AND FUNDING SCENARIO               110

5.8           TECHNOLOGY ANALYSIS             111

5.8.1        KEY TECHNOLOGIES     111

5.8.1.1    Single-use technology          111

5.8.1.2    Flow cytometry     113

5.8.1.3    Microscopy            113

5.8.2        COMPLEMENTARY TECHNOLOGIES       114

5.8.2.1    High-throughput screening                 114

5.8.2.2    Mass spectrometry                114

5.8.3        ADJACENT TECHNOLOGIES       114

5.8.3.1    Microfluidics and organ-on-a-chip    114

5.8.3.2    3D bioprinting      115

5.9           PATENT ANALYSIS          115

5.10         TRADE ANALYSIS             118

5.10.1      IMPORT DATA  119

5.10.2      EXPORT DATA  121

5.11         KEY CONFERENCES AND EVENTS, 2025–2026        123

5.12         TARIFF AND REGULATORY LANDSCAPE               124

5.12.1      TARIFF RELATED TO CELL CULTURE PRODUCTS                 124

5.12.2      REGULATORY FRAMEWORK       124

5.12.2.1  North America      124

5.12.2.2  Europe   125

5.12.2.3  Asia Pacific            126

5.12.2.4  Latin America       126

5.12.2.5  Middle East & Africa            127

5.12.3      REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS             127

5.13         PORTER’S FIVE FORCES ANALYSIS           131

5.13.1      BARGAINING POWER OF SUPPLIERS       132

5.13.2      BARGAINING POWER OF BUYERS             132

5.13.3      THREAT OF NEW ENTRANTS      132

5.13.4      THREAT OF SUBSTITUTES          132

5.13.5      INTENSITY OF COMPETITIVE RIVALRY 132

5.14         KEY STAKEHOLDERS AND BUYING CRITERIA     133

5.14.1      KEY STAKEHOLDERS IN BUYING PROCESS           133

5.14.2      KEY BUYING CRITERIA  134

5.15         IMPACT OF AI/GENERATIVE AI ON CELL CULTURE PRODUCTS MARKET      135

5.15.1      INTRODUCTION              135

5.15.2      MARKET POTENTIAL OF AI IN CELL CULTURE APPLICATIONS 136

5.15.3      AI USE CASES     136

5.15.4      KEY COMPANIES IMPLEMENTING AI      137

5.15.5      FUTURE OF GENERATIVE AI IN CELL CULTURE ECOSYSTEM       137

5.16         IMPACT OF 2025 US TARIFF ON CELL CULTURE MARKET                 137

5.16.1      INTRODUCTION              137

5.16.2      KEY TARIFF RATES          138

5.16.3      PRICE IMPACT ANALYSIS             139

5.16.4      IMPACT ON COUNTRY/REGION                139

5.16.4.1  US           139

5.16.4.2  Europe   140

5.16.4.3  Asia Pacific            140

5.16.5      IMPACT ON END-USE INDUSTRIES          140

5.16.5.1  Pharmaceutical & biotech companies                141

5.16.5.2  Hospitals & diagnostic laboratories   141

5.16.5.3  Academic & research institutes          141

5.16.5.4  Contract research organizations & contract development and manufacturing organizations              142

6               CELL CULTURE MARKET, BY PRODUCT                 143

6.1           INTRODUCTION              144

6.2           CONSUMABLES 144

6.2.1        SERA, MEDIA, AND REAGENTS   148

6.2.1.1    Media     152

6.2.1.1.1 Serum-free media 156

6.2.1.1.1.1              Enhanced control, reproducibility, and decreased batch-to-batch variability to aid growth       156

6.2.1.1.2 Classical media & salts         161

6.2.1.1.2.1              Need for efficient and scalable vaccine production to bolster growth       161

6.2.1.1.3 Stem cell culture media       165

6.2.1.1.3.1              Rising funding and support for stem cell-based research and therapy to augment growth         165

6.2.1.1.4 Chemically-defined media  168

6.2.1.1.4.1              Rising need for reproducibility, regulatory compliance, and precise control in cell culture systems to aid growth                168

6.2.1.1.5 Specialty media     172

6.2.1.1.5.1              Suitability for use in selective cell types in bioprocessing and biomanufacturing industries to boost market           172

6.2.1.1.6 Other media          176

6.2.1.2    Reagents                 180

6.2.1.2.1 Growth factors      184

6.2.1.2.1.1              Need to regulate cell proliferation, differentiation, and migration to sustain growth                184

6.2.1.2.2 Supplements          188

6.2.1.2.2.1              Growing acquisitions and expansions by cell culture vendors to propel market    188

6.2.1.2.3 Buffers & chemicals             191

6.2.1.2.3.1              Ability to maintain stable pH levels to facilitate growth                 191

6.2.1.2.4 Cell dissociation reagents    195

6.2.1.2.4.1              Ability to minimize cell stress and reduce cell damage to foster growth         195

6.2.1.2.5 Balanced salt solutions        198

6.2.1.2.5.1              Ability to maintain optimal physiological conditions for cell growth and experimentation to assist growth            198

6.2.1.2.6 Attachment & matrix factors               202

6.2.1.2.6.1              Rising adoption of 3D cell culture models to support growth    202

6.2.1.2.7 Antibiotics/Antimycotics    205

6.2.1.2.7.1              Ability to mitigate growth of contaminating bacteria, fungi, and mycoplasma to drive market            205

6.2.1.2.8 Cryoprotective reagents      209

6.2.1.2.8.1              Ability to preserve cell viability during freezing and thawing to aid growth          209

6.2.1.2.9 Contamination detection kits             212

6.2.1.2.9.1              Need for rapid identification of microbial contaminants to promote growth                212

6.2.1.2.10                Other reagents      216

6.2.1.3    Sera         219

6.2.1.3.1 Fetal bovine sera  223

6.2.1.3.1.1              Increasing role of fetal bovine sera in cell proliferation to favor growth      223

6.2.1.3.2 Adult bovine sera 227

6.2.1.3.2.1              Cost-effectiveness to contribute to growth       227

6.2.1.3.3 Other animal sera 230

6.2.2        VESSELS               234

6.2.2.1    Cell factory systems/cell stacks          237

6.2.2.1.1 Efficient and scalable solutions for large-scale expansion to drive adoption 237

6.2.2.2    Roller/roux bottles                241

6.2.2.2.1 Scalability, cost-effectiveness, and ease of handling to support growth    241

6.2.2.3    Flasks     244

6.2.2.3.1 Growing advancements in cell culture flasks to boost market                 244

6.2.2.4    Multiwell plates    248

6.2.2.4.1 Increasing adoption of multiwell plates in high-throughput or high-content screening to aid growth                248

6.2.2.5    Petri dishes            251

6.2.2.5.1 Rising use of petri dishes as sterile containers to sustain growth                 251

6.2.3        ACCESSORIES    255

6.2.3.1    Reduced preparation time and equipment performance improvements to augment growth     255

6.3           EQUIPMENT      258

6.3.1        BIOREACTORS  261

6.3.1.1    Conventional bioreactors    265

6.3.1.1.1 Utilization in large-scale manufacturing of drugs to drive market                 265

6.3.1.2    Single-use bioreactors          268

6.3.1.2.1 Lower operational costs and increased flexibility to boost market                 268

6.3.2        STORAGE EQUIPMENT 273

6.3.2.1    Refrigerators & freezers       276

6.3.2.1.1 Increasing need for storage solutions to propel market  276

6.3.2.2    Cryostorage systems             280

6.3.2.2.1 Benefits of long-term preservation of cell cultures to support growth    280

6.3.3        OTHER EQUIPMENT      284

6.3.3.1    Filtration systems 287

6.3.3.1.1 Growing use in bioprocessing industry to boost market 287

6.3.3.2    Cell counters         291

6.3.3.2.1 Growing adoption of automated cell counters to propel market                 291

6.3.3.3    Carbon dioxide incubators  295

6.3.3.3.1 Increasing focus of research institutes on developing lab-scale incubators to drive market  295

6.3.3.4    Centrifuges            299

6.3.3.4.1 Increasing demand for bioproduction applications to drive adoption of centrifuges        299

6.3.3.5    Autoclaves              304

6.3.3.5.1 Reliance on single-use labware and equipment to affect demand for autoclaves        304

6.3.3.6    Microscopes          307

6.3.3.6.1 Enhanced imaging capabilities to augment growth         307

6.3.3.7    Biosafety cabinets 311

6.3.3.7.1 Increasing launches of biosafety cabinets to promote growth                 311

6.3.3.8    Other supporting equipment              315

7               CELL CULTURE MARKET, BY APPLICATION        319

7.1           INTRODUCTION              320

7.2           BIOPHARMACEUTICAL PRODUCTION   320

7.2.1        MONOCLONAL ANTIBODY PRODUCTION           324

7.2.1.1    Increasing approval and launch of mAb candidates to amplify growth    324

7.2.2        VACCINE PRODUCTION                328

7.2.2.1    Rising incidence of infectious diseases to support growth                 328

7.2.3        OTHER THERAPEUTIC PROTEIN PRODUCTION                 332

7.3           DIAGNOSTICS   336

7.3.1        GROWING ADVANCEMENTS AND ADOPTION OF NEW TECHNIQUES TO FUEL MARKET               336

7.4           TISSUE ENGINEERING & REGENERATIVE MEDICINE                 339

7.4.1        CELL & GENE THERAPY 344

7.4.1.1    Rising investments in developing cell-based immunotherapies to foster growth         344

7.4.2        OTHER TISSUE ENGINEERING & REGENERATIVE MEDICINE APPLICATIONS           348

7.5           DRUG SCREENING & DEVELOPMENT     351

7.5.1        INCREASING FOCUS ON BIOLOGIC DRUGS TO FAVOR GROWTH             351

7.6           OTHER APPLICATIONS 355

8               CELL CULTURE MARKET, BY END USER                 359

8.1           INTRODUCTION              360

8.2           PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES                 360

8.2.1        INCREASING DEMAND FOR CULTURE CELL LINES FOR DRUG SCREENING AND R&D TO AID GROWTH 360

8.3           HOSPITALS & DIAGNOSTIC LABORATORIES       365

8.3.1        GROWING USE OF CELL CULTURE FOR CELLULAR PHYSIOLOGY, DISEASE MECHANISMS, AND DRUG RESPONSES TO BOOST MARKET        365

8.4           RESEARCH & ACADEMIC INSTITUTES    369

8.4.1        RISING FUNDING ACTIVITIES TO CONTRIBUTE TO GROWTH             369

8.5           OTHER END USERS         372

9               CELL CULTURE MARKET, BY REGION    377

9.1           INTRODUCTION              378

9.2           NORTH AMERICA             378

9.2.1        MACROECONOMIC OUTLOOK FOR NORTH AMERICA                 379

9.2.2        US           387

9.2.2.1    Advanced healthcare infrastructure and government support to bolster growth       387

9.2.3        CANADA               395

9.2.3.1    Increasing funding and investments for cell-based therapies to boost market          395

9.3           EUROPE               402

9.3.1        MACROECONOMIC OUTLOOK FOR EUROPE      402

9.3.2        GERMANY           409

9.3.2.1    Rising R&D investments and strategic alliances to promote growth    409

9.3.3        UK          417

9.3.3.1    Growth in life science industry and favorable government investments to drive market                417

9.3.4        FRANCE                424

9.3.4.1    Rising number of cell-based research projects to enhance growth                 424

9.3.5        ITALY    431

9.3.5.1    Strong government support for R&D activities to spur growth                 431

9.3.6        SPAIN    437

9.3.6.1    Booming biotechnology industry to bolster growth        437

9.3.7        REST OF EUROPE             445

9.4           ASIA PACIFIC     452

9.4.1        MACROECONOMIC OUTLOOK FOR ASIA PACIFIC                 453

9.4.2        CHINA  461

9.4.2.1    Rising focus on stem cell & regenerative medicine research to expedite growth    461

9.4.3        JAPAN   468

9.4.3.1    Rising government initiatives and increasing investments in biotech to intensify growth 468

9.4.4        INDIA    476

9.4.4.1    Favorable government support and expansion by key cell culture players to augment growth 476

9.4.5        SOUTH KOREA  483

9.4.5.1    Growing pharmaceutical sector to drive market              483

9.4.6        AUSTRALIA         490

9.4.6.1    Increasing prevalence of chronic diseases to accelerate growth                 490

9.4.7        REST OF ASIA PACIFIC   497

9.5           LATIN AMERICA                504

9.5.1        MACROECONOMIC OUTLOOK FOR LATIN AMERICA                 504

9.5.2        BRAZIL 512

9.5.2.1    Rising prevalence of cancer and related research activities to support growth      512

9.5.3        MEXICO                518

9.5.3.1    Increasing advancements in biotechnology industry to spur growth    518

9.5.4        REST OF LATIN AMERICA             525

9.6           MIDDLE EAST   533

9.6.1        MACROECONOMIC OUTLOOK FOR MIDDLE EAST                 533

9.6.2        GCC COUNTRIES              541

9.6.2.1    Saudi Arabia          548

9.6.2.1.1 Increasing focus of key players on expansion to drive market                 548

9.6.2.2    UAE        555

9.6.2.2.1 Increasing shift from importing to manufacturing pharmaceuticals to boost market        555

9.6.2.3    Rest of GCC Countries        562

9.6.3        REST OF MIDDLE EAST 569

9.7           AFRICA 576

9.7.1        RISING GRANTS AND FUNDING FOR CELL AND GENE THERAPY PRODUCTS TO FOSTER GROWTH       576

9.7.2        MACROECONOMIC OUTLOOK FOR AFRICA        577

10            COMPETITIVE LANDSCAPE         584

10.1         OVERVIEW          584

10.2         KEY PLAYER STRATEGIES/RIGHT TO WIN            584

10.2.1      OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN CELL CULTURE MARKET              585

10.3         REVENUE ANALYSIS, 2020–2024  587

10.4         MARKET SHARE ANALYSIS, 2024                 588

10.5         COMPANY VALUATION AND FINANCIAL METRICS                 590

10.6         BRAND/PRODUCT COMPARISON             592

10.7         COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024                 593

10.7.1      STARS   593

10.7.2      EMERGING LEADERS     593

10.7.3      PERVASIVE PLAYERS      593

10.7.4      PARTICIPANTS 593

10.7.5      COMPANY FOOTPRINT: KEY PLAYERS, 2024         595

10.7.5.1  Company footprint               595

10.7.5.2  Region footprint   596

10.7.5.3  Product footprint  597

10.7.5.4  Application footprint            598

10.7.5.5  End-user footprint                599

10.8         COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024        600

10.8.1      PROGRESSIVE COMPANIES         600

10.8.2      RESPONSIVE COMPANIES            600

10.8.3      DYNAMIC COMPANIES  600

10.8.4      STARTING BLOCKS         600

10.8.5      COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024                 602

10.8.5.1  Detailed list of key startups/SMEs    602

10.8.5.2  Competitive benchmarking of key startups/SMEs          603

10.9         COMPETITIVE SCENARIO             603

10.9.1      PRODUCT LAUNCHES   604

10.9.2      DEALS  605

10.9.3      EXPANSIONS     607

11            COMPANY PROFILES      609

11.1         INTRODUCTION              609

11.2         KEY PLAYERS     609

11.2.1      THERMO FISHER SCIENTIFIC INC.            609

11.2.1.1  Business overview 609

11.2.1.2  Products offered   611

11.2.1.3  Recent developments           625

11.2.1.3.1                Product launches  625

11.2.1.3.2                Deals      627

11.2.1.3.3                Expansions             627

11.2.1.4  MnM view              630

11.2.1.4.1                Key strengths        630

11.2.1.4.2                Strategic choices   630

11.2.1.4.3                Weaknesses and competitive threats 630

11.2.2      DANAHER            631

11.2.2.1  Business overview 631

11.2.2.2  Products offered   632

11.2.2.3  Recent developments           643

11.2.2.3.1                Product launches  643

11.2.2.3.2                Deals      644

11.2.2.3.3                Expansions             645

11.2.2.3.4                Other developments             647

11.2.2.4  MnM view              647

11.2.2.4.1                Key strengths        647

11.2.2.4.2                Strategic choices   647

11.2.2.4.3                Weaknesses and competitive threats 647

11.2.3      MERCK KGAA    648

11.2.3.1  Business overview 648

11.2.3.2  Products offered   649

11.2.3.3  Recent developments           656

11.2.3.3.1                Product launches  656

11.2.3.3.2                Deals      656

11.2.3.3.3                Expansions             657

11.2.3.4  MnM view              659

11.2.3.4.1                Key strengths        659

11.2.3.4.2                Strategic choices   659

11.2.3.4.3                Weaknesses and competitive threats 659

11.2.4      SARTORIUS AG 660

11.2.4.1  Business overview 660

11.2.4.2  Products offered   661

11.2.4.3  Recent developments           669

11.2.4.3.1                Product launches  669

11.2.4.3.2                Deals      669

11.2.4.3.3                Expansions             672

11.2.5      CORNING INCORPORATED         673

11.2.5.1  Business overview 673

11.2.5.2  Products offered   674

11.2.5.3  Recent developments           684

11.2.5.3.1                Product launches  684

11.2.5.3.2                Deals      685

11.2.6      FUJIFILM HOLDINGS CORPORATION     686

11.2.6.1  Business overview 686

11.2.6.2  Products offered   687

11.2.6.3  Recent developments           694

11.2.6.3.1                Product launches  694

11.2.6.3.2                Deals      694

11.2.6.3.3                Expansions             695

11.2.6.3.4                Other developments             696

11.2.7      BD          697

11.2.7.1  Business overview 697

11.2.7.2  Product offered     698

11.2.7.3  Recent developments           700

11.2.7.3.1                Product Launches 700

11.2.7.3.2                Deals      701

11.2.8      EPPENDORF SE 702

11.2.8.1  Business overview 702

11.2.8.2  Products offered   703

11.2.8.3  Recent developments           708

11.2.8.3.1                Product launches  708

11.2.8.3.2                Deals      709

11.2.8.3.3                Expansions             709

11.2.9      LONZA 711

11.2.9.1  Business overview 711

11.2.9.2  Products offered   712

11.2.9.3  Recent developments           715

11.2.9.3.1                Product launches  715

11.2.9.3.2                Deals      716

11.2.10   GETINGE             717

11.2.10.1                 Business overview 717

11.2.10.2                 Products offered   718

11.2.10.3                 Recent developments           719

11.2.10.3.1             Product launches  719

11.2.10.3.2             Deals      720

11.2.10.3.3             Expansions             721

11.2.11   AGILENT TECHNOLOGIES, INC.                722

11.2.11.1                 Business overview 722

11.2.11.2                 Products offered   723

11.2.11.3                 Recent developments           725

11.2.11.3.1             Product launches  725

11.2.11.3.2             Deals      726

11.2.11.3.3             Expansions             726

11.2.12   HIMEDIA LABORATORIES            727

11.2.12.1                 Business overview 727

11.2.12.2                 Products offered   727

11.2.13   BIO-TECHNE     731

11.2.13.1                 Business overview 731

11.2.13.2                 Products offered   732

11.2.13.3                 Recent developments           736

11.2.13.3.1             Product launches  736

11.2.13.3.2             Deals      736

11.2.13.3.3             Expansions             737

11.3         OTHER PLAYERS              738

11.3.1      MILTENYI BIOTEC           738

11.3.2      STEMCELL TECHNOLOGIES       740

11.3.3      SOLIDA BIOTECH GMBH              743

11.3.4      CAISSON LABS  744

11.3.5      PROMOCELL GMBH        745

11.3.6      INVIVOGEN        746

11.3.7      PAN-BIOTECH  747

11.3.8      CELLEXUS           748

11.3.9      MEISSNER FILTRATION PRODUCTS, INC.              749

11.3.10   ADOLF KÜHNER AG        751

11.3.11   ADVANCION CORPORATION      752

11.3.12   BIOSPHERIX LLC               753

12            APPENDIX           754

12.1         DISCUSSION GUIDE        754

12.2         KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL                759

12.3         CUSTOMIZATION OPTIONS        761

12.4         RELATED REPORTS         762

12.5         AUTHOR DETAILS           764

LIST OF TABLES

TABLE 1                CELL CULTURE MARKET: INCLUSIONS AND EXCLUSIONS      61

TABLE 2                IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS              72

TABLE 3                CELL CULTURE MARKET: RISK ANALYSIS                 76

TABLE 4                CELL CULTURE MARKET: IMPACT ANALYSIS OF MARKET DYNAMICS       84

TABLE 5                NATIONAL INSTITUTES OF HEALTH FUNDING FOR STEM CELL-BASED RESEARCH, 2020–2024 (USD MILLION)                 85

TABLE 6                FUNDING INVESTMENTS IN CELL & GENE THERAPY, 2023 – 2025      86

TABLE 7                COMMERCIALLY SPONSORED MONOCLONAL ANTIBODY THERAPEUTICS GRANTED FIRST APPROVAL IN 2024                 89

TABLE 8                ASIA PACIFIC: PRIVATE ROUNDS IN BIOTECH COMPANIES FOCUSED ON HEALTHCARE, 2023-2025         98

TABLE 9                COMPARISON OF SINGLE-USE BIOPROCESSING SYSTEM DISPOSAL OPTIONS      101

TABLE 10              AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT, 2022–2024            105

TABLE 11              AVERAGE SELLING PRICE OF SINGLE-USE ASSEMBLIES, BY REGION, 2024   105

TABLE 12              AVERAGE SELLING PRICE OF MEDIA, BY DEVELOPING VS.

DEVELOPED COUNTRIES, 2024  106

TABLE 13              CELL CULTURE MARKET: ROLE OF COMPANIES IN ECOSYSTEM 109

TABLE 14              ADVANTAGES OF SINGLE-USE AND STAINLESS-STEEL BIOREACTORS    113

TABLE 15              ADVANTAGES AND DISADVANTAGES OF MICROFLUIDIC CELL CULTURE                 114

TABLE 16              CELL CULTURE MARKET: INNOVATIONS AND PATENT REGISTRATIONS, 2025  117

TABLE 17              IMPORT DATA FOR HS CODE 382100, 2020–2024 (USD THOUSAND)           119

TABLE 18              IMPORT DATA FOR HS CODE 382100, 2020–2024 (TONS) 120

TABLE 19              EXPORT DATA FOR HS CODE 382100, 2020–2024 (USD THOUSAND)           121

TABLE 20              EXPORT DATA FOR HS CODE 382100, 2020–2024 (TONS) 122

TABLE 21              CELL CULTURE MARKET: KEY CONFERENCES AND EVENTS, 2025–2026                 123

TABLE 22              AVERAGE TARIFF RELATED TO CELL CULTURE PRODUCTS FOR

HS CODE 382100, 2024     124

TABLE 23              NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  127

TABLE 24              EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  128

TABLE 25              ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  129

TABLE 26              REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  130

TABLE 27              CELL CULTURE MARKET: PORTER’S FIVE FORCES ANALYSIS           131

TABLE 28              BUYING CRITERIA FOR CELL CULTURE PRODUCTS, BY END USER            134

TABLE 29              US ADJUSTED RECIPROCAL TARIFF RATES                 138

TABLE 30              CELL CULTURE PRODUCTS-RELATED TARIFF REVISION            139

TABLE 31              IMPACT ON END-USE APPLICATIONS OF CELL-BASED ASSAY PRODUCTS             141

TABLE 32              CELL CULTURE MARKET, BY PRODUCT, 2023–2030 (USD MILLION)       144

TABLE 33              CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)                144

TABLE 34              CELL CULTURE CONSUMABLES MARKET, BY REGION, 2023–2030 (USD MILLION)          145

TABLE 35              NORTH AMERICA: CELL CULTURE CONSUMABLES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            145

TABLE 36              EUROPE: CELL CULTURE CONSUMABLES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            146

TABLE 37              ASIA PACIFIC: CELL CULTURE CONSUMABLES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            146

TABLE 38              LATIN AMERICA: CELL CULTURE CONSUMABLES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            147

TABLE 39              MIDDLE EAST: CELL CULTURE CONSUMABLES MARKET, BY REGION,

2023–2030 (USD MILLION)            147

TABLE 40              GCC COUNTRIES: CELL CULTURE CONSUMABLES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            147

TABLE 41              CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            148

TABLE 42              CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY REGION,

2023–2030 (USD MILLION)            149

TABLE 43              NORTH AMERICA: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               149

TABLE 44              EUROPE: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               150

TABLE 45              ASIA PACIFIC: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               150

TABLE 46              LATIN AMERICA: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               151

TABLE 47              MIDDLE EAST: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET,

BY REGION, 2023–2030 (USD MILLION)   151

TABLE 48              GCC COUNTRIES: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               151

TABLE 49              CELL CULTURE MEDIA MARKET, BY TYPE, 2023–2030 (USD MILLION)       152

TABLE 50              CELL CULTURE MEDIA MARKET, BY REGION, 2023–2030 (USD MILLION)            153

TABLE 51              CELL CULTURE MEDIA MARKET, BY REGION, 2023–2030 (MILLION LITERS)       153

TABLE 52              NORTH AMERICA: CELL CULTURE MEDIA MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            154

TABLE 53              EUROPE: CELL CULTURE MEDIA MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            154

TABLE 54              ASIA PACIFIC: CELL CULTURE MEDIA MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            155

TABLE 55              LATIN AMERICA: CELL CULTURE MEDIA MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            155

TABLE 56              MIDDLE EAST: CELL CULTURE MEDIA MARKET, BY REGION,

2023–2030 (USD MILLION)            155

TABLE 57              GCC COUNTRIES: CELL CULTURE MEDIA MARKET, BY COUNTRY,

2023–2030 (USD MILLION)          156

TABLE 58              SERUM-FREE MEDIA OFFERED BY KEY MARKET PLAYERS              157

TABLE 59              CELL CULTURE MARKET FOR SERUM-FREE MEDIA, BY REGION,

2023–2030 (USD MILLION)            158

TABLE 60              NORTH AMERICA: CELL CULTURE MARKET FOR SERUM-FREE MEDIA, BY COUNTRY, 2023–2030 (USD MILLION)                 158

TABLE 61              EUROPE: CELL CULTURE MARKET FOR SERUM-FREE MEDIA, BY COUNTRY,

2023–2030 (USD MILLION)            159

TABLE 62              ASIA PACIFIC: CELL CULTURE MARKET FOR SERUM-FREE MEDIA, BY COUNTRY, 2023–2030 (USD MILLION)                 159

TABLE 63              LATIN AMERICA: CELL CULTURE MARKET FOR SERUM-FREE MEDIA, BY COUNTRY, 2023–2030 (USD MILLION)                 160

TABLE 64              MIDDLE EAST: CELL CULTURE MARKET FOR SERUM-FREE MEDIA, BY REGION, 2023–2030 (USD MILLION)                 160

TABLE 65              GCC COUNTRIES: CELL CULTURE MARKET FOR SERUM-FREE MEDIA, BY COUNTRY, 2023–2030 (USD MILLION)                 160

TABLE 66              CLASSICAL MEDIA & SALTS OFFERED BY KEY MARKET PLAYERS           161

TABLE 67              CELL CULTURE MARKET FOR CLASSICAL MEDIA & SALTS, BY REGION,

2023–2030 (USD MILLION)            162

TABLE 68              NORTH AMERICA: CELL CULTURE MARKET FOR CLASSICAL MEDIA & SALTS,

BY COUNTRY, 2023–2030 (USD MILLION)               162

TABLE 69              EUROPE: CELL CULTURE MARKET FOR CLASSICAL MEDIA & SALTS, BY COUNTRY, 2023–2030 (USD MILLION)            163

TABLE 70              ASIA PACIFIC: CELL CULTURE MARKET FOR CLASSICAL MEDIA & SALTS,

BY COUNTRY, 2023–2030 (USD MILLION)               163

TABLE 71              LATIN AMERICA: CELL CULTURE MARKET FOR CLASSICAL MEDIA & SALTS,

BY COUNTRY, 2023–2030 (USD MILLION)               164

TABLE 72              MIDDLE EAST: CELL CULTURE MARKET FOR CLASSICAL MEDIA & SALTS,

BY REGION, 2023–2030 (USD MILLION)   164

TABLE 73              GCC COUNTRIES: CELL CULTURE MARKET FOR CLASSICAL MEDIA & SALTS,

BY COUNTRY, 2023–2030 (USD MILLION)               164

TABLE 74              STEM CELL CULTURE MEDIA OFFERED BY KEY MARKET PLAYERS           165

TABLE 75              CELL CULTURE MARKET FOR STEM CELL CULTURE MEDIA, BY REGION,

2023–2030 (USD MILLION)            165

TABLE 76              NORTH AMERICA: CELL CULTURE MARKET FOR STEM CELL CULTURE MEDIA,

BY COUNTRY, 2023–2030 (USD MILLION)               166

TABLE 77              EUROPE: CELL CULTURE MARKET FOR STEM CELL CULTURE MEDIA, BY COUNTRY, 2023–2030 (USD MILLION)                 166

TABLE 78              ASIA PACIFIC: CELL CULTURE MARKET FOR STEM CELL CULTURE MEDIA,

BY COUNTRY, 2023–2030 (USD MILLION)               167

TABLE 79              LATIN AMERICA: CELL CULTURE MARKET FOR STEM CELL CULTURE MEDIA,

BY COUNTRY, 2023–2030 (USD MILLION)               167

TABLE 80              MIDDLE EAST: CELL CULTURE MARKET FOR STEM CELL CULTURE MEDIA,

BY REGION, 2023–2030 (USD MILLION)   168

TABLE 81              GCC COUNTRIES: CELL CULTURE MARKET FOR STEM CELL CULTURE MEDIA,

BY COUNTRY, 2023–2030 (USD MILLION)               168

TABLE 82              CHEMICALLY-DEFINED MEDIA OFFERED BY KEY MARKET PLAYERS  169

TABLE 83              CELL CULTURE MARKET FOR CHEMICALLY-DEFINED MEDIA, BY REGION,

2023–2030 (USD MILLION)            169

TABLE 84              NORTH AMERICA: CELL CULTURE MARKET FOR CHEMICALLY-DEFINED MEDIA,

BY COUNTRY, 2023–2030 (USD MILLION)               170

TABLE 85              EUROPE: CELL CULTURE MARKET FOR CHEMICALLY-DEFINED MEDIA,

BY COUNTRY, 2023–2030 (USD MILLION)               170

TABLE 86              ASIA PACIFIC: CELL CULTURE MARKET FOR CHEMICALLY-DEFINED MEDIA,

BY COUNTRY, 2023–2030 (USD MILLION)               171

TABLE 87              LATIN AMERICA: CELL CULTURE MARKET FOR CHEMICALLY-DEFINED MEDIA,

BY COUNTRY, 2023–2030 (USD MILLION)               171

TABLE 88              MIDDLE EAST: CELL CULTURE MARKET FOR CHEMICALLY-DEFINED MEDIA,

BY REGION, 2023–2030 (USD MILLION)   172

TABLE 89              GCC COUNTRIES: CELL CULTURE MARKET FOR CHEMICALLY-DEFINED MEDIA,

BY COUNTRY, 2023–2030 (USD MILLION)               172

TABLE 90              SPECIALTY MEDIA OFFERED BY KEY MARKET PLAYERS              173

TABLE 91              CELL CULTURE MARKET FOR SPECIALTY MEDIA, BY REGION,

2023–2030 (USD MILLION)            173

TABLE 92              NORTH AMERICA: CELL CULTURE MARKET FOR SPECIALTY MEDIA, BY COUNTRY, 2023–2030 (USD MILLION)                 174

TABLE 93              EUROPE: CELL CULTURE MARKET FOR SPECIALTY MEDIA, BY COUNTRY,

2023–2030 (USD MILLION)            174

TABLE 94              ASIA PACIFIC: CELL CULTURE MARKET FOR SPECIALTY MEDIA, BY COUNTRY, 2023–2030 (USD MILLION)                 175

TABLE 95              LATIN AMERICA: CELL CULTURE MARKET FOR SPECIALTY MEDIA, BY COUNTRY, 2023–2030 (USD MILLION)                 175

TABLE 96              MIDDLE EAST: CELL CULTURE MARKET FOR SPECIALTY MEDIA, BY REGION,

2023–2030 (USD MILLION)            176

TABLE 97              GCC COUNTRIES: CELL CULTURE MARKET FOR SPECIALTY MEDIA, BY COUNTRY, 2023–2030 (USD MILLION)                 176

TABLE 98              OTHER MEDIA OFFERED BY KEY MARKET PLAYERS              177

TABLE 99              CELL CULTURE MARKET FOR OTHER MEDIA, BY REGION,

2023–2030 (USD MILLION)            177

TABLE 100            NORTH AMERICA: CELL CULTURE MARKET FOR OTHER MEDIA, BY COUNTRY, 2023–2030 (USD MILLION)                 178

TABLE 101            EUROPE: CELL CULTURE MARKET FOR OTHER MEDIA, BY COUNTRY,

2023–2030 (USD MILLION)            178

TABLE 102            ASIA PACIFIC: CELL CULTURE MARKET FOR OTHER MEDIA, BY COUNTRY,

2023–2030 (USD MILLION)            179

TABLE 103            LATIN AMERICA: CELL CULTURE MARKET FOR OTHER MEDIA, BY COUNTRY,

2023–2030 (USD MILLION)            179

TABLE 104            MIDDLE EAST: CELL CULTURE MARKET FOR OTHER MEDIA, BY REGION,

2023–2030 (USD MILLION)            180

TABLE 105            GCC COUNTRIES: CELL CULTURE MARKET FOR OTHER MEDIA, BY COUNTRY, 2023–2030 (USD MILLION)                 180

TABLE 106            CELL CULTURE REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)            181

TABLE 107            CELL CULTURE REAGENTS MARKET, BY REGION, 2023–2030 (USD MILLION)          181

TABLE 108            NORTH AMERICA: CELL CULTURE REAGENTS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            182

TABLE 109            EUROPE: CELL CULTURE REAGENTS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            182

TABLE 110            ASIA PACIFIC: CELL CULTURE REAGENTS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            183

TABLE 111            LATIN AMERICA: CELL CULTURE REAGENTS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            183

TABLE 112            MIDDLE EAST: CELL CULTURE REAGENTS MARKET, BY REGION,

2023–2030 (USD MILLION)            184

TABLE 113            GCC COUNTRIES: CELL CULTURE REAGENTS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            184

TABLE 114            CELL CULTURE MARKET FOR GROWTH FACTORS, BY REGION,

2023–2030 (USD MILLION)            185

TABLE 115            NORTH AMERICA: CELL CULTURE MARKET FOR GROWTH FACTORS, BY COUNTRY, 2023–2030 (USD MILLION)                 185

TABLE 116            EUROPE: CELL CULTURE MARKET FOR GROWTH FACTORS, BY COUNTRY,

2023–2030 (USD MILLION)            186

TABLE 117            ASIA PACIFIC: CELL CULTURE MARKET FOR GROWTH FACTORS, BY COUNTRY, 2023–2030 (USD MILLION)                 186

TABLE 118            LATIN AMERICA: CELL CULTURE MARKET FOR GROWTH FACTORS, BY COUNTRY, 2023–2030 (USD MILLION)                 187

TABLE 119            MIDDLE EAST: CELL CULTURE MARKET FOR GROWTH FACTORS, BY REGION, 2023–2030 (USD MILLION)                 187

TABLE 120            GCC COUNTRIES: CELL CULTURE MARKET FOR GROWTH FACTORS, BY COUNTRY, 2023–2030 (USD MILLION)                 187

TABLE 121            CELL CULTURE MARKET FOR SUPPLEMENTS, BY REGION,

2023–2030 (USD MILLION)            188

TABLE 122            NORTH AMERICA: CELL CULTURE MARKET FOR SUPPLEMENTS, BY COUNTRY, 2023–2030 (USD MILLION)                 189

TABLE 123            EUROPE: CELL CULTURE MARKET FOR SUPPLEMENTS, BY COUNTRY,

2023–2030 (USD MILLION)            189

TABLE 124            ASIA PACIFIC: CELL CULTURE MARKET FOR SUPPLEMENTS, BY COUNTRY,

2023–2030 (USD MILLION)            190

TABLE 125            LATIN AMERICA: CELL CULTURE MARKET FOR SUPPLEMENTS, BY COUNTRY, 2023–2030 (USD MILLION)                 190

TABLE 126            MIDDLE EAST: CELL CULTURE MARKET FOR SUPPLEMENTS, BY REGION,

2023–2030 (USD MILLION)            191

TABLE 127            GCC COUNTRIES: CELL CULTURE MARKET FOR SUPPLEMENTS, BY COUNTRY, 2023–2030 (USD MILLION)                 191

TABLE 128            CELL CULTURE MARKET FOR BUFFERS & CHEMICALS, BY REGION,

2023–2030 (USD MILLION)            192

TABLE 129            NORTH AMERICA: CELL CULTURE MARKET FOR BUFFERS & CHEMICALS,

BY COUNTRY, 2023–2030 (USD MILLION)               192

TABLE 130            EUROPE: CELL CULTURE MARKET FOR BUFFERS & CHEMICALS, BY COUNTRY, 2023–2030 (USD MILLION)            193

TABLE 131            ASIA PACIFIC: CELL CULTURE MARKET FOR BUFFERS & CHEMICALS, BY COUNTRY, 2023–2030 (USD MILLION)            193

TABLE 132            LATIN AMERICA: CELL CULTURE MARKET FOR BUFFERS & CHEMICALS,

BY COUNTRY, 2023–2030 (USD MILLION)               194

TABLE 133            MIDDLE EAST: CELL CULTURE MARKET FOR BUFFERS & CHEMICALS,

BY REGION, 2023–2030 (USD MILLION)   194

TABLE 134            GCC COUNTRIES: CELL CULTURE MARKET FOR BUFFERS & CHEMICALS,

BY COUNTRY, 2023–2030 (USD MILLION)               194

TABLE 135            CELL CULTURE MARKET FOR CELL DISSOCIATION REAGENTS, BY REGION,

2023–2030 (USD MILLION)            195

TABLE 136            NORTH AMERICA: CELL CULTURE MARKET FOR CELL DISSOCIATION REAGENTS,

BY COUNTRY, 2023–2030 (USD MILLION)               196

TABLE 137            EUROPE: CELL CULTURE MARKET FOR CELL DISSOCIATION REAGENTS,

BY COUNTRY, 2023–2030 (USD MILLION)               196

TABLE 138            ASIA PACIFIC: CELL CULTURE MARKET FOR CELL DISSOCIATION REAGENTS,

BY COUNTRY, 2023–2030 (USD MILLION)               197

TABLE 139            LATIN AMERICA: CELL CULTURE MARKET FOR CELL DISSOCIATION REAGENTS,

BY COUNTRY, 2023–2030 (USD MILLION)               197

TABLE 140            MIDDLE EAST: CELL CULTURE MARKET FOR CELL DISSOCIATION REAGENTS,

BY REGION, 2023–2030 (USD MILLION)   198

TABLE 141            GCC COUNTRIES: CELL CULTURE MARKET FOR CELL DISSOCIATION REAGENTS,

BY COUNTRY, 2023–2030 (USD MILLION)               198

TABLE 142            CELL CULTURE MARKET FOR BALANCED SALT SOLUTIONS, BY REGION,

2023–2030 (USD MILLION)            199

TABLE 143            NORTH AMERICA: CELL CULTURE MARKET FOR BALANCED SALT SOLUTIONS,

BY COUNTRY, 2023–2030 (USD MILLION)               199

TABLE 144            EUROPE: CELL CULTURE MARKET FOR BALANCED SALT SOLUTIONS,

BY COUNTRY, 2023–2030 (USD MILLION)               200

TABLE 145            ASIA PACIFIC: CELL CULTURE MARKET FOR BALANCED SALT SOLUTIONS,

BY COUNTRY, 2023–2030 (USD MILLION)               200

TABLE 146            LATIN AMERICA: CELL CULTURE MARKET FOR BALANCED SALT SOLUTIONS,

BY COUNTRY, 2023–2030 (USD MILLION)               201

TABLE 147            MIDDLE EAST: CELL CULTURE MARKET FOR BALANCED SALT SOLUTIONS,

BY REGION, 2023–2030 (USD MILLION)   201

TABLE 148            GCC COUNTRIES: CELL CULTURE MARKET FOR BALANCED SALT SOLUTIONS,

BY COUNTRY, 2023–2030 (USD MILLION)               201

TABLE 149            CELL CULTURE MARKET FOR ATTACHMENT & MATRIX FACTORS, BY REGION, 2023–2030 (USD MILLION)                 202

TABLE 150            NORTH AMERICA: CELL CULTURE MARKET FOR ATTACHMENT & MATRIX FACTORS, BY COUNTRY, 2023–2030 (USD MILLION) 203

TABLE 151            EUROPE: CELL CULTURE MARKET FOR ATTACHMENT & MATRIX FACTORS,

BY COUNTRY, 2023–2030 (USD MILLION)               203

TABLE 152            ASIA PACIFIC: CELL CULTURE MARKET FOR ATTACHMENT & MATRIX FACTORS,

BY COUNTRY, 2023–2030 (USD MILLION)               204

TABLE 153            LATIN AMERICA: CELL CULTURE MARKET FOR ATTACHMENT & MATRIX FACTORS, BY COUNTRY, 2023–2030 (USD MILLION) 204

TABLE 154            MIDDLE EAST: CELL CULTURE MARKET FOR ATTACHMENT & MATRIX FACTORS,

BY REGION, 2023–2030 (USD MILLION)   205

TABLE 155            GCC COUNTRIES: CELL CULTURE MARKET FOR ATTACHMENT & MATRIX FACTORS, BY COUNTRY, 2023–2030 (USD MILLION) 205

TABLE 156            CELL CULTURE MEDIA FOR ANTIBIOTICS/ANTIMYCOTICS, BY REGION,

2023–2030 (USD MILLION)            206

TABLE 157            NORTH AMERICA: CELL CULTURE MEDIA FOR ANTIBIOTICS/ANTIMYCOTICS,

BY COUNTRY, 2023–2030 (USD MILLION)               206

TABLE 158            EUROPE: CELL CULTURE MEDIA FOR ANTIBIOTICS/ANTIMYCOTICS, BY COUNTRY, 2023–2030 (USD MILLION)            207

TABLE 159            ASIA PACIFIC: CELL CULTURE MEDIA FOR ANTIBIOTICS/ANTIMYCOTICS,

BY COUNTRY, 2023–2030 (USD MILLION)               207

TABLE 160            LATIN AMERICA: CELL CULTURE MEDIA FOR ANTIBIOTICS/ANTIMYCOTICS,

BY COUNTRY, 2023–2030 (USD MILLION)               208

TABLE 161            MIDDLE EAST: CELL CULTURE MEDIA FOR ANTIBIOTICS/ANTIMYCOTICS,

BY REGION, 2023–2030 (USD MILLION)   208

TABLE 162            GCC COUNTRIES: CELL CULTURE MEDIA FOR ANTIBIOTICS/ANTIMYCOTICS,

BY COUNTRY, 2023–2030 (USD MILLION)               208

TABLE 163            CELL CULTURE MARKET FOR CRYOPROTECTIVE REAGENTS, BY REGION,

2023–2030 (USD MILLION)            209

TABLE 164            NORTH AMERICA: CELL CULTURE MARKET FOR CRYOPROTECTIVE REAGENTS,

BY COUNTRY, 2023–2030 (USD MILLION)               210

TABLE 165            EUROPE: CELL CULTURE MARKET FOR CRYOPROTECTIVE REAGENTS,

BY COUNTRY, 2023–2030 (USD MILLION)               210

TABLE 166            ASIA PACIFIC: CELL CULTURE MARKET FOR CRYOPROTECTIVE REAGENTS,

BY COUNTRY, 2023–2030 (USD MILLION)               211

TABLE 167            LATIN AMERICA: CELL CULTURE MARKET FOR CRYOPROTECTIVE REAGENTS,

BY COUNTRY, 2023–2030 (USD MILLION)               211

TABLE 168            MIDDLE EAST: CELL CULTURE MARKET FOR CRYOPROTECTIVE REAGENTS,

BY REGION, 2023–2030 (USD MILLION)   212

TABLE 169            GCC COUNTRIES: CELL CULTURE MARKET FOR CRYOPROTECTIVE REAGENTS,

BY COUNTRY, 2023–2030 (USD MILLION)               212

TABLE 170            CELL CULTURE MARKET FOR CONTAMINATION DETECTION KITS, BY REGION, 2023–2030 (USD MILLION) 213

TABLE 171            NORTH AMERICA: CELL CULTURE MARKET FOR CONTAMINATION DETECTION KITS, BY COUNTRY, 2023–2030 (USD MILLION) 213

TABLE 172            EUROPE: CELL CULTURE MARKET FOR CONTAMINATION DETECTION KITS,

BY COUNTRY, 2023–2030 (USD MILLION)               214

TABLE 173            ASIA PACIFIC: CELL CULTURE MARKET FOR CONTAMINATION DETECTION KITS,

BY COUNTRY, 2023–2030 (USD MILLION)               214

TABLE 174            LATIN AMERICA: CELL CULTURE MARKET FOR CONTAMINATION DETECTION KITS, BY COUNTRY, 2023–2030 (USD MILLION) 215

TABLE 175            MIDDLE EAST: CELL CULTURE MARKET FOR CONTAMINATION DETECTION KITS,

BY REGION, 2023–2030 (USD MILLION)   215

TABLE 176            GCC COUNTRIES: CELL CULTURE MARKET FOR CONTAMINATION DETECTION KITS, BY COUNTRY, 2023–2030 (USD MILLION) 215

TABLE 177            CELL CULTURE MARKET FOR OTHER REAGENTS, BY REGION,

2023–2030 (USD MILLION)            216

TABLE 178            NORTH AMERICA: CELL CULTURE MARKET FOR OTHER REAGENTS, BY COUNTRY, 2023–2030 (USD MILLION)                 217

TABLE 179            EUROPE: CELL CULTURE MARKET FOR OTHER REAGENTS, BY COUNTRY,

2023–2030 (USD MILLION)            217

TABLE 180            ASIA PACIFIC: CELL CULTURE MARKET FOR OTHER REAGENTS, BY COUNTRY, 2023–2030 (USD MILLION)                 218

TABLE 181            LATIN AMERICA: CELL CULTURE MARKET FOR OTHER REAGENTS, BY COUNTRY, 2023–2030 (USD MILLION)                 218

TABLE 182            MIDDLE EAST: CELL CULTURE MARKET FOR OTHER REAGENTS, BY REGION, 2023–2030 (USD MILLION)                 219

TABLE 183            GCC COUNTRIES: CELL CULTURE MARKET FOR OTHER REAGENTS, BY COUNTRY, 2023–2030 (USD MILLION)                 219

TABLE 184            CELL CULTURE SERA MARKET, BY TYPE, 2023–2030 (USD MILLION)       220

TABLE 185            CELL CULTURE SERA MARKET, BY REGION, 2023–2030 (USD MILLION)            220

TABLE 186            NORTH AMERICA: CELL CULTURE SERA MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            221

TABLE 187            EUROPE: CELL CULTURE SERA MARKET, BY COUNTRY, 2023–2030 (USD MILLION)     221

TABLE 188            ASIA PACIFIC: CELL CULTURE SERA MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            222

TABLE 189            LATIN AMERICA: CELL CULTURE SERA MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            222

TABLE 190            MIDDLE EAST: CELL CULTURE SERA MARKET, BY REGION,

2023–2030 (USD MILLION)            222

TABLE 191            GCC COUNTRIES: CELL CULTURE SERA MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            223

TABLE 192            CELL CULTURE MEDIA FOR FETAL BOVINE SERA, BY REGION,

2023–2030 (USD MILLION)            224

TABLE 193            NORTH AMERICA: CELL CULTURE MEDIA FOR FETAL BOVINE SERA, BY COUNTRY, 2023–2030 (USD MILLION)                 224

TABLE 194            EUROPE: CELL CULTURE MEDIA FOR FETAL BOVINE SERA, BY COUNTRY,

2023–2030 (USD MILLION)          225

TABLE 195            ASIA PACIFIC: CELL CULTURE MEDIA FOR FETAL BOVINE SERA, BY COUNTRY, 2023–2030 (USD MILLION)                 225

TABLE 196            LATIN AMERICA: CELL CULTURE MEDIA FOR FETAL BOVINE SERA, BY COUNTRY, 2023–2030 (USD MILLION)                 226

TABLE 197            MIDDLE EAST: CELL CULTURE MEDIA FOR FETAL BOVINE SERA, BY REGION, 2023–2030 (USD MILLION)                 226

TABLE 198            GCC COUNTRIES: CELL CULTURE MEDIA FOR FETAL BOVINE SERA, BY COUNTRY, 2023–2030 (USD MILLION)                 226

TABLE 199            CELL CULTURE MEDIA FOR ADULT BOVINE SERA, BY REGION,

2023–2030 (USD MILLION)            227

TABLE 200            NORTH AMERICA: CELL CULTURE MEDIA FOR ADULT BOVINE SERA, BY COUNTRY, 2023–2030 (USD MILLION)                 227

TABLE 201            EUROPE: CELL CULTURE MEDIA FOR ADULT BOVINE SERA, BY COUNTRY,

2023–2030 (USD MILLION)            228

TABLE 202            ASIA PACIFIC: CELL CULTURE MEDIA FOR ADULT BOVINE SERA, BY COUNTRY, 2023–2030 (USD MILLION)                 228

TABLE 203            LATIN AMERICA: CELL CULTURE MEDIA FOR ADULT BOVINE SERA, BY COUNTRY, 2023–2030 (USD MILLION)                 229

TABLE 204            MIDDLE EAST: CELL CULTURE MEDIA FOR ADULT BOVINE SERA, BY REGION, 2023–2030 (USD MILLION)                 229

TABLE 205            GCC COUNTRIES: CELL CULTURE MEDIA FOR ADULT BOVINE SERA, BY COUNTRY, 2023–2030 (USD MILLION)                 229

TABLE 206            CELL CULTURE MARKET FOR OTHER ANIMAL SERA, BY REGION,

2023–2030 (USD MILLION)            231

TABLE 207            NORTH AMERICA: CELL CULTURE MARKET FOR OTHER ANIMAL SERA,

BY COUNTRY, 2023–2030 (USD MILLION)               231

TABLE 208            EUROPE: CELL CULTURE MARKET FOR OTHER ANIMAL SERA, BY COUNTRY,

2023–2030 (USD MILLION)            232

TABLE 209            ASIA PACIFIC: CELL CULTURE MARKET FOR OTHER ANIMAL SERA, BY COUNTRY, 2023–2030 (USD MILLION)                 232

TABLE 210            LATIN AMERICA: CELL CULTURE MARKET FOR OTHER ANIMAL SERA, BY COUNTRY, 2023–2030 (USD MILLION)                 233

TABLE 211            MIDDLE EAST: CELL CULTURE MARKET FOR OTHER ANIMAL SERA, BY REGION, 2023–2030 (USD MILLION)                 233

TABLE 212            GCC COUNTRIES: CELL CULTURE MARKET FOR OTHER ANIMAL SERA,

BY COUNTRY, 2023–2030 (USD MILLION)               233

TABLE 213            CELL CULTURE VESSELS MARKET, BY TYPE, 2023–2030 (USD MILLION)            234

TABLE 214            CELL CULTURE VESSELS MARKET, BY REGION, 2023–2030 (USD MILLION)            234

TABLE 215            NORTH AMERICA: CELL CULTURE VESSELS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)          235

TABLE 216            EUROPE: CELL CULTURE VESSELS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            235

TABLE 217          ASIA PACIFIC: CELL CULTURE VESSELS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            236

TABLE 218            LATIN AMERICA: CELL CULTURE VESSELS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            236

TABLE 219            MIDDLE EAST: CELL CULTURE VESSELS MARKET, BY REGION,

2023–2030 (USD MILLION)            236

TABLE 220            GCC COUNTRIES: CELL CULTURE VESSELS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            237

TABLE 221            CELL CULTURE MARKET FOR CELL FACTORY SYSTEMS/CELL STACKS, BY REGION, 2023–2030 (USD MILLION)                 238

TABLE 222            NORTH AMERICA: CELL CULTURE MARKET FOR CELL FACTORY SYSTEMS/

CELL STACKS, BY COUNTRY, 2023–2030 (USD MILLION) 238

TABLE 223            EUROPE: CELL CULTURE MARKET FOR CELL FACTORY SYSTEMS/CELL STACKS,

BY COUNTRY, 2023–2030 (USD MILLION)               239

TABLE 224            ASIA PACIFIC: CELL CULTURE MARKET FOR CELL FACTORY SYSTEMS/CELL STACKS, BY COUNTRY, 2023–2030 (USD MILLION)       239

TABLE 225            LATIN AMERICA: CELL CULTURE MARKET FOR CELL FACTORY SYSTEMS/

CELL STACKS, BY COUNTRY, 2023–2030 (USD MILLION) 240

TABLE 226            MIDDLE EAST: CELL CULTURE MARKET FOR CELL FACTORY SYSTEMS/

CELL STACKS, BY REGION, 2023–2030 (USD MILLION)     240

TABLE 227            GCC COUNTRIES: CELL CULTURE MARKET FOR CELL FACTORY SYSTEMS/

CELL STACKS, BY COUNTRY, 2023–2030 (USD MILLION) 240

TABLE 228            CELL CULTURE MARKET FOR ROLLER/ROUX BOTTLES, BY REGION,

2023–2030 (USD MILLION)            241

TABLE 229            NORTH AMERICA: CELL CULTURE MARKET FOR ROLLER/ROUX BOTTLES,

BY COUNTRY, 2023–2030 (USD MILLION)               242

TABLE 230            EUROPE: CELL CULTURE MARKET FOR ROLLER/ROUX BOTTLES, BY COUNTRY, 2023–2030 (USD MILLION)            242

TABLE 231            ASIA PACIFIC: CELL CULTURE MARKET FOR ROLLER/ROUX BOTTLES,

BY COUNTRY, 2023–2030 (USD MILLION)               243

TABLE 232            LATIN AMERICA: CELL CULTURE MARKET FOR ROLLER/ROUX BOTTLES,

BY COUNTRY, 2023–2030 (USD MILLION)               243

TABLE 233            MIDDLE EAST: CELL CULTURE MARKET FOR ROLLER/ROUX BOTTLES, BY REGION, 2023–2030 (USD MILLION)                 244

TABLE 234            GCC COUNTRIES: CELL CULTURE MARKET FOR ROLLER/ROUX BOTTLES,

BY COUNTRY, 2023–2030 (USD MILLION)               244

TABLE 235            CELL CULTURE MARKET FOR FLASKS, BY REGION, 2023–2030 (USD MILLION)          245

TABLE 236            NORTH AMERICA: CELL CULTURE MARKET FOR FLASKS, BY COUNTRY,

2023–2030 (USD MILLION)            245

TABLE 237            EUROPE: CELL CULTURE MARKET FOR FLASKS, BY COUNTRY,

2023–2030 (USD MILLION)            246

TABLE 238            ASIA PACIFIC: CELL CULTURE MARKET FOR FLASKS, BY COUNTRY,

2023–2030 (USD MILLION)            246

TABLE 239            LATIN AMERICA: CELL CULTURE MARKET FOR FLASKS, BY COUNTRY,

2023–2030 (USD MILLION)            247

TABLE 240            MIDDLE EAST: CELL CULTURE MARKET FOR FLASKS, BY REGION,

2023–2030 (USD MILLION)            247

TABLE 241            GCC COUNTRIES: CELL CULTURE MARKET FOR FLASKS, BY COUNTRY,

2023–2030 (USD MILLION)          247

TABLE 242            CELL CULTURE MARKET FOR MULTIWELL PLATES, BY REGION,

2023–2030 (USD MILLION)            248

TABLE 243            NORTH AMERICA: CELL CULTURE MARKET FOR MULTIWELL PLATES, BY COUNTRY, 2023–2030 (USD MILLION)                 249

TABLE 244            EUROPE: CELL CULTURE MARKET FOR MULTIWELL PLATES, BY COUNTRY,

2023–2030 (USD MILLION)            249

TABLE 245            ASIA PACIFIC: CELL CULTURE MARKET FOR MULTIWELL PLATES, BY COUNTRY, 2023–2030 (USD MILLION)                 250

TABLE 246            LATIN AMERICA: CELL CULTURE MARKET FOR MULTIWELL PLATES, BY COUNTRY, 2023–2030 (USD MILLION)                 250

TABLE 247            MIDDLE EAST: CELL CULTURE MARKET FOR MULTIWELL PLATES, BY REGION, 2023–2030 (USD MILLION)                 251

TABLE 248            GCC COUNTRIES: CELL CULTURE MARKET FOR MULTIWELL PLATES, BY COUNTRY, 2023–2030 (USD MILLION)                 251

TABLE 249            CELL CULTURE MARKET FOR PETRI DISHES, BY REGION,

2023–2030 (USD MILLION)            252

TABLE 250            NORTH AMERICA: CELL CULTURE MARKET FOR PETRI DISHES,

BY COUNTRY, 2023–2030 (USD MILLION)               252

TABLE 251            EUROPE: CELL CULTURE MARKET FOR PETRI DISHES, BY COUNTRY,

2023–2030 (USD MILLION)            253

TABLE 252            ASIA PACIFIC: CELL CULTURE MARKET FOR PETRI DISHES, BY COUNTRY,

2023–2030 (USD MILLION)            253

TABLE 253            LATIN AMERICA: CELL CULTURE MARKET FOR PETRI DISHES, BY COUNTRY,

2023–2030 (USD MILLION)            254

TABLE 254            MIDDLE EAST: CELL CULTURE MARKET FOR PETRI DISHES, BY REGION,

2023–2030 (USD MILLION)            254

TABLE 255            GCC COUNTRIES: CELL CULTURE MARKET FOR PETRI DISHES, BY COUNTRY, 2023–2030 (USD MILLION)                 254

TABLE 256            CELL CULTURE ACCESSORIES MARKET, BY REGION, 2023–2030 (USD MILLION)          255

TABLE 257            NORTH AMERICA: CELL CULTURE ACCESSORIES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            255

TABLE 258            EUROPE: CELL CULTURE ACCESSORIES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            256

TABLE 259            ASIA PACIFIC: CELL CULTURE ACCESSORIES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            256

TABLE 260            LATIN AMERICA: CELL CULTURE ACCESSORIES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            257

TABLE 261            MIDDLE EAST: CELL CULTURE ACCESSORIES MARKET, BY REGION,

2023–2030 (USD MILLION)            257

TABLE 262            GCC COUNTRIES: CELL CULTURE ACCESSORIES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            257

TABLE 263            CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2023–2030 (USD MILLION)            258

TABLE 264            CELL CULTURE EQUIPMENT MARKET, BY REGION, 2023–2030 (USD MILLION)          258

TABLE 265            NORTH AMERICA: CELL CULTURE EQUIPMENT MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            259

TABLE 266            EUROPE: CELL CULTURE EQUIPMENT MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            259

TABLE 267            ASIA PACIFIC: CELL CULTURE EQUIPMENT MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            260

TABLE 268            LATIN AMERICA: CELL CULTURE EQUIPMENT MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            260

TABLE 269            MIDDLE EAST: CELL CULTURE EQUIPMENT MARKET, BY REGION,

2023–2030 (USD MILLION)            261

TABLE 270            GCC COUNTRIES: CELL CULTURE EQUIPMENT MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            261

TABLE 271            CELL CULTURE MARKET FOR BIOREACTORS, BY TYPE, 2023–2030 (USD MILLION)         262

TABLE 272            CELL CULTURE MARKET FOR BIOREACTORS, BY REGION,

2023–2030 (USD MILLION)          262

TABLE 273            NORTH AMERICA: CELL CULTURE MARKET FOR BIOREACTORS, BY COUNTRY, 2023–2030 (USD MILLION)                 262

TABLE 274            EUROPE: CELL CULTURE MARKET FOR BIOREACTORS, BY COUNTRY,

2023–2030 (USD MILLION)            263

TABLE 275            ASIA PACIFIC: CELL CULTURE MARKET FOR BIOREACTORS, BY COUNTRY,

2023–2030 (USD MILLION)            263

TABLE 276            LATIN AMERICA: CELL CULTURE MARKET FOR BIOREACTORS, BY COUNTRY,

2023–2030 (USD MILLION)            264

TABLE 277            MIDDLE EAST: CELL CULTURE MARKET FOR BIOREACTORS, BY REGION,

2023–2030 (USD MILLION)            264

TABLE 278            GCC COUNTRIES: CELL CULTURE MARKET FOR BIOREACTORS, BY COUNTRY, 2023–2030 (USD MILLION)                 264

TABLE 279            CELL CULTURE MARKET FOR CONVENTIONAL BIOREACTORS, BY REGION,

2023–2030 (USD MILLION)            265

TABLE 280            NORTH AMERICA: CELL CULTURE MARKET FOR CONVENTIONAL BIOREACTORS,

BY COUNTRY, 2023–2030 (USD MILLION)               266

TABLE 281            EUROPE: CELL CULTURE MARKET FOR CONVENTIONAL BIOREACTORS,

BY COUNTRY, 2023–2030 (USD MILLION)               266

TABLE 282            ASIA PACIFIC: CELL CULTURE MARKET FOR CONVENTIONAL BIOREACTORS,

BY COUNTRY, 2023–2030 (USD MILLION)               267

TABLE 283            LATIN AMERICA: CELL CULTURE MARKET FOR CONVENTIONAL BIOREACTORS,

BY COUNTRY, 2023–2030 (USD MILLION)               267

TABLE 284            MIDDLE EAST: CELL CULTURE MARKET FOR CONVENTIONAL BIOREACTORS,

BY REGION, 2023–2030 (USD MILLION)   268

TABLE 285            GCC COUNTRIES: CELL CULTURE MARKET FOR CONVENTIONAL BIOREACTORS,

BY COUNTRY, 2023–2030 (USD MILLION)               268

TABLE 286            COMMERCIALLY AVAILABLE SINGLE-USE BIOREACTORS BY KEY PLAYERS                269

TABLE 287            CELL CULTURE MARKET FOR SINGLE-USE BIOREACTORS, BY REGION,

2023–2030 (USD MILLION)            270

TABLE 288            NORTH AMERICA: CELL CULTURE MARKET FOR SINGLE-USE BIOREACTORS,

BY COUNTRY, 2023–2030 (USD MILLION)               270

TABLE 289            EUROPE: CELL CULTURE MARKET FOR SINGLE-USE BIOREACTORS, BY COUNTRY, 2023–2030 (USD MILLION)                 271

TABLE 290            ASIA PACIFIC: CELL CULTURE MARKET FOR SINGLE-USE BIOREACTORS,

BY COUNTRY, 2023–2030 (USD MILLION)               271

TABLE 291            LATIN AMERICA: CELL CULTURE MARKET FOR SINGLE-USE BIOREACTORS,

BY COUNTRY, 2023–2030 (USD MILLION)               272

TABLE 292            MIDDLE EAST: CELL CULTURE MARKET FOR SINGLE-USE BIOREACTORS,

BY REGION, 2023–2030 (USD MILLION)   272

TABLE 293            GCC COUNTRIES: CELL CULTURE MARKET FOR SINGLE-USE BIOREACTORS,

BY COUNTRY, 2023–2030 (USD MILLION)               272

TABLE 294            CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY TYPE,

2023–2030 (USD MILLION)            273

TABLE 295            CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY REGION,

2023–2030 (USD MILLION)          273

TABLE 296            NORTH AMERICA: CELL CULTURE MARKET FOR STORAGE EQUIPMENT,

BY COUNTRY, 2023–2030 (USD MILLION)               274

TABLE 297            EUROPE: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY COUNTRY, 2023–2030 (USD MILLION)                 274

TABLE 298            ASIA PACIFIC: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY COUNTRY, 2023–2030 (USD MILLION)                 275

TABLE 299            LATIN AMERICA: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY COUNTRY, 2023–2030 (USD MILLION)                 275

TABLE 300            MIDDLE EAST: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY REGION, 2023–2030 (USD MILLION)                 276

TABLE 301            GCC COUNTRIES: CELL CULTURE MARKET FOR STORAGE EQUIPMENT,

BY COUNTRY, 2023–2030 (USD MILLION)               276

TABLE 302            CELL CULTURE MARKET FOR REFRIGERATORS & FREEZERS, BY REGION,

2023–2030 (USD MILLION)            277

TABLE 303            NORTH AMERICA: CELL CULTURE MARKET FOR REFRIGERATORS & FREEZERS,

BY COUNTRY, 2023–2030 (USD MILLION)               277

TABLE 304            EUROPE: CELL CULTURE MARKET FOR REFRIGERATORS & FREEZERS,

BY COUNTRY, 2023–2030 (USD MILLION)               278

TABLE 305            ASIA PACIFIC: CELL CULTURE MARKET FOR REFRIGERATORS & FREEZERS,

BY COUNTRY, 2023–2030 (USD MILLION)               278

TABLE 306            LATIN AMERICA: CELL CULTURE MARKET FOR REFRIGERATORS & FREEZERS,

BY COUNTRY, 2023–2030 (USD MILLION)               279

TABLE 307            MIDDLE EAST: CELL CULTURE MARKET FOR REFRIGERATORS & FREEZERS,

BY REGION, 2023–2030 (USD MILLION)   279

TABLE 308            GCC COUNTRIES: CELL CULTURE MARKET FOR REFRIGERATORS & FREEZERS,

BY COUNTRY, 2023–2030 (USD MILLION)               279

TABLE 309            CELL CULTURE MARKET FOR CRYOSTORAGE SYSTEMS, BY REGION,

2023–2030 (USD MILLION)            281

TABLE 310            NORTH AMERICA: CELL CULTURE MARKET FOR CRYOSTORAGE SYSTEMS,

BY COUNTRY, 2023–2030 (USD MILLION)               281

TABLE 311            EUROPE: CELL CULTURE MARKET FOR CRYOSTORAGE SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION)            282

TABLE 312            ASIA PACIFIC: CELL CULTURE MARKET FOR CRYOSTORAGE SYSTEMS,

BY COUNTRY, 2023–2030 (USD MILLION)               282

TABLE 313            LATIN AMERICA: CELL CULTURE MARKET FOR CRYOSTORAGE SYSTEMS,

BY COUNTRY, 2023–2030 (USD MILLION)               283

TABLE 314            MIDDLE EAST: CELL CULTURE MARKET FOR CRYOSTORAGE SYSTEMS,

BY REGION, 2023–2030 (USD MILLION)   283

TABLE 315            GCC COUNTRIES: CELL CULTURE MARKET FOR CRYOSTORAGE SYSTEMS,

BY COUNTRY, 2023–2030 (USD MILLION)               283

TABLE 316            CELL CULTURE MARKET FOR OTHER EQUIPMENT, BY TYPE,

2023–2030 (USD MILLION)            284

TABLE 317            CELL CULTURE MARKET FOR OTHER EQUIPMENT, BY REGION,

2023–2030 (USD MILLION)            284

TABLE 318            NORTH AMERICA: CELL CULTURE MARKET FOR OTHER EQUIPMENT, BY COUNTRY, 2023–2030 (USD MILLION)                 285

TABLE 319            EUROPE: CELL CULTURE MARKET FOR OTHER EQUIPMENT, BY COUNTRY,

2023–2030 (USD MILLION)            285

TABLE 320            ASIA PACIFIC: CELL CULTURE MARKET FOR OTHER EQUIPMENT, BY COUNTRY, 2023–2030 (USD MILLION)                 286

TABLE 321            LATIN AMERICA: CELL CULTURE MARKET FOR OTHER EQUIPMENT, BY COUNTRY, 2023–2030 (USD MILLION)                 286

TABLE 322            MIDDLE EAST: CELL CULTURE MARKET FOR OTHER EQUIPMENT, BY REGION, 2023–2030 (USD MILLION)                 287

TABLE 323            GCC COUNTRIES: CELL CULTURE MARKET FOR OTHER EQUIPMENT, BY COUNTRY, 2023–2030 (USD MILLION)                 287

TABLE 324            FILTRATION SYSTEMS OFFERED BY KEY PLAYERS              288

TABLE 325            CELL CULTURE MARKET FOR FILTRATION SYSTEMS, BY REGION,

2023–2030 (USD MILLION)            288

TABLE 326            NORTH AMERICA: CELL CULTURE MARKET FOR FILTRATION SYSTEMS,

BY COUNTRY, 2023–2030 (USD MILLION)               289

TABLE 327            EUROPE: CELL CULTURE MARKET FOR FILTRATION SYSTEMS, BY COUNTRY,

2023–2030 (USD MILLION)            289

TABLE 328            ASIA PACIFIC: CELL CULTURE MARKET FOR FILTRATION SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION)                 290

TABLE 329            LATIN AMERICA: CELL CULTURE MARKET FOR FILTRATION SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION)                 290

TABLE 330            MIDDLE EAST: CELL CULTURE MARKET FOR FILTRATION SYSTEMS, BY REGION, 2023–2030 (USD MILLION)                 291

TABLE 331            GCC COUNTRIES: CELL CULTURE MARKET FOR FILTRATION SYSTEMS,

BY COUNTRY, 2023–2030 (USD MILLION)               291

TABLE 332            CELL COUNTERS OFFERED BY KEY MARKET PLAYERS              292

TABLE 333            CELL CULTURE MARKET FOR CELL COUNTERS, BY REGION,

2023–2030 (USD MILLION)            292

TABLE 334            NORTH AMERICA: CELL CULTURE MARKET FOR CELL COUNTERS, BY COUNTRY, 2023–2030 (USD MILLION)                 293

TABLE 335            EUROPE: CELL CULTURE MARKET FOR CELL COUNTERS, BY COUNTRY,

2023–2030 (USD MILLION)            293

TABLE 336            ASIA PACIFIC: CELL CULTURE MARKET FOR CELL COUNTERS, BY COUNTRY,

2023–2030 (USD MILLION)            294

TABLE 337            LATIN AMERICA: CELL CULTURE MARKET FOR CELL COUNTERS, BY COUNTRY, 2023–2030 (USD MILLION)                 294

TABLE 338            MIDDLE EAST: CELL CULTURE MARKET FOR CELL COUNTERS, BY REGION,

2023–2030 (USD MILLION)            295

TABLE 339            GCC COUNTRIES: CELL CULTURE MARKET FOR CELL COUNTERS, BY COUNTRY, 2023–2030 (USD MILLION)                 295

TABLE 340            CARBON DIOXIDE INCUBATORS OFFERED BY KEY MARKET PLAYERS  296

TABLE 341            CELL CULTURE MARKET FOR CARBON DIOXIDE INCUBATORS, BY REGION,

2023–2030 (USD MILLION)            296

TABLE 342            NORTH AMERICA: CELL CULTURE MARKET FOR CARBON DIOXIDE INCUBATORS,

BY COUNTRY, 2023–2030 (USD MILLION)               297

TABLE 343            EUROPE: CELL CULTURE MARKET FOR CARBON DIOXIDE INCUBATORS,

BY COUNTRY, 2023–2030 (USD MILLION)               297

TABLE 344            ASIA PACIFIC: CELL CULTURE MARKET FOR CARBON DIOXIDE INCUBATORS,

BY COUNTRY, 2023–2030 (USD MILLION)               298

TABLE 345            LATIN AMERICA: CELL CULTURE MARKET FOR CARBON DIOXIDE INCUBATORS,

BY COUNTRY, 2023–2030 (USD MILLION)               298

TABLE 346            MIDDLE EAST: CELL CULTURE MARKET FOR CARBON DIOXIDE INCUBATORS,

BY REGION, 2023–2030 (USD MILLION)   299

TABLE 347            GCC COUNTRIES: CELL CULTURE MARKET FOR CARBON DIOXIDE INCUBATORS,

BY COUNTRY, 2023–2030 (USD MILLION)               299

TABLE 348            CENTRIFUGES OFFERED BY KEY MARKET PLAYERS              300

TABLE 349            CELL CULTURE MARKET FOR CENTRIFUGES, BY REGION,

2023–2030 (USD MILLION)            301

TABLE 350            NORTH AMERICA: CELL CULTURE MARKET FOR CENTRIFUGES,

BY COUNTRY, 2023–2030 (USD MILLION)               301

TABLE 351            EUROPE: CELL CULTURE MARKET FOR CENTRIFUGES, BY COUNTRY,

2023–2030 (USD MILLION)            302

TABLE 352            ASIA PACIFIC: CELL CULTURE MARKET FOR CENTRIFUGES, BY COUNTRY,

2023–2030 (USD MILLION)            302

TABLE 353            LATIN AMERICA: CELL CULTURE MARKET FOR CENTRIFUGES, BY COUNTRY,

2023–2030 (USD MILLION)            303

TABLE 354            MIDDLE EAST: CELL CULTURE MARKET FOR CENTRIFUGES, BY REGION,

2023–2030 (USD MILLION)            303

TABLE 355            GCC COUNTRIES: CELL CULTURE MARKET FOR CENTRIFUGES, BY COUNTRY, 2023–2030 (USD MILLION)                 303

TABLE 356            CELL CULTURE MARKET FOR AUTOCLAVES, BY REGION,

2023–2030 (USD MILLION)            304

TABLE 357            NORTH AMERICA: CELL CULTURE MARKET FOR AUTOCLAVES, BY COUNTRY,

2023–2030 (USD MILLION)            305

TABLE 358            EUROPE: CELL CULTURE MARKET FOR AUTOCLAVES, BY COUNTRY,

2023–2030 (USD MILLION)            305

TABLE 359            ASIA PACIFIC: CELL CULTURE MARKET FOR AUTOCLAVES, BY COUNTRY,

2023–2030 (USD MILLION)            306

TABLE 360            LATIN AMERICA: CELL CULTURE MARKET FOR AUTOCLAVES, BY COUNTRY,

2023–2030 (USD MILLION)            306

TABLE 361            MIDDLE EAST: CELL CULTURE MARKET FOR AUTOCLAVES, BY REGION,

2023–2030 (USD MILLION)            307

TABLE 362            GCC COUNTRIES: CELL CULTURE MARKET FOR AUTOCLAVES, BY COUNTRY,

2023–2030 (USD MILLION)            307

TABLE 363            CELL CULTURE MARKET FOR MICROSCOPES, BY REGION,

2023–2030 (USD MILLION)            308

TABLE 364            NORTH AMERICA: CELL CULTURE MARKET FOR MICROSCOPES, BY COUNTRY, 2023–2030 (USD MILLION)                 308

TABLE 365            EUROPE: CELL CULTURE MARKET FOR MICROSCOPES, BY COUNTRY,

2023–2030 (USD MILLION)            309

TABLE 366            ASIA PACIFIC: CELL CULTURE MARKET FOR MICROSCOPES, BY COUNTRY,

2023–2030 (USD MILLION)            309

TABLE 367            LATIN AMERICA: CELL CULTURE MARKET FOR MICROSCOPES, BY COUNTRY, 2023–2030 (USD MILLION)                 310

TABLE 368            MIDDLE EAST: CELL CULTURE MARKET FOR MICROSCOPES, BY REGION,

2023–2030 (USD MILLION)            310

TABLE 369            GCC COUNTRIES: CELL CULTURE MARKET FOR MICROSCOPES, BY COUNTRY, 2023–2030 (USD MILLION)                 310

TABLE 370            BIOSAFETY CABINETS OFFERED BY KEY MARKET PLAYERS           311

TABLE 371            CELL CULTURE MARKET FOR BIOSAFETY CABINETS, BY REGION,

2023–2030 (USD MILLION)            312

TABLE 372            NORTH AMERICA: CELL CULTURE MARKET FOR BIOSAFETY CABINETS,

BY COUNTRY, 2023–2030 (USD MILLION)               312

TABLE 373            EUROPE: CELL CULTURE MARKET FOR BIOSAFETY CABINETS, BY COUNTRY,

2023–2030 (USD MILLION)            313

TABLE 374            ASIA PACIFIC: CELL CULTURE MARKET FOR BIOSAFETY CABINETS, BY COUNTRY, 2023–2030 (USD MILLION)                 313

TABLE 375            LATIN AMERICA: CELL CULTURE MARKET FOR BIOSAFETY CABINETS, BY COUNTRY, 2023–2030 (USD MILLION)                 314

TABLE 376            MIDDLE EAST: CELL CULTURE MARKET FOR BIOSAFETY CABINETS, BY REGION, 2023–2030 (USD MILLION)                 314

TABLE 377            GCC COUNTRIES: CELL CULTURE MARKET FOR BIOSAFETY CABINETS,

BY COUNTRY, 2023–2030 (USD MILLION)               314

TABLE 378            OTHER SUPPORTING EQUIPMENT OFFERED BY KEY MARKET PLAYERS  315

TABLE 379            CELL CULTURE MARKET FOR OTHER SUPPORTING EQUIPMENT, BY REGION, 2023–2030 (USD MILLION)            315

TABLE 380            NORTH AMERICA: CELL CULTURE MARKET FOR OTHER SUPPORTING EQUIPMENT, BY COUNTRY, 2023–2030 (USD MILLION) 316

TABLE 381            EUROPE: CELL CULTURE MARKET FOR OTHER SUPPORTING EQUIPMENT,

BY COUNTRY, 2023–2030 (USD MILLION)               316

TABLE 382            ASIA PACIFIC: CELL CULTURE MARKET FOR OTHER SUPPORTING EQUIPMENT,

BY COUNTRY, 2023–2030 (USD MILLION)               317

TABLE 383            LATIN AMERICA: CELL CULTURE MARKET FOR OTHER SUPPORTING EQUIPMENT, BY COUNTRY, 2023–2030 (USD MILLION) 317

TABLE 384            MIDDLE EAST: CELL CULTURE MARKET FOR OTHER SUPPORTING EQUIPMENT,

BY REGION, 2023–2030 (USD MILLION)   318

TABLE 385            GCC COUNTRIES: CELL CULTURE MARKET FOR OTHER SUPPORTING EQUIPMENT, BY COUNTRY, 2023–2030 (USD MILLION) 318

TABLE 386            CELL CULTURE MARKET, BY APPLICATION, 2023–2030 (USD MILLION)            320

TABLE 387            CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE,

2023–2030 (USD MILLION)            321

TABLE 388            CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY REGION, 2023–2030 (USD MILLION) 321

TABLE 389            NORTH AMERICA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY COUNTRY, 2023–2030 (USD MILLION) 322

TABLE 390            EUROPE: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION,

BY COUNTRY, 2023–2030 (USD MILLION)               322

TABLE 391            ASIA PACIFIC: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY COUNTRY, 2023–2030 (USD MILLION) 323

TABLE 392            LATIN AMERICA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY COUNTRY, 2023–2030 (USD MILLION) 323

TABLE 393            MIDDLE EAST: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY REGION, 2023–2030 (USD MILLION) 324

TABLE 394            GCC COUNTRIES: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY COUNTRY, 2023–2030 (USD MILLION) 324

TABLE 395            CELL CULTURE MARKET FOR MONOCLONAL ANTIBODY PRODUCTION, BY REGION, 2023–2030 (USD MILLION)            325

TABLE 396            NORTH AMERICA: CELL CULTURE MARKET FOR MONOCLONAL ANTIBODY PRODUCTION, BY COUNTRY, 2023–2030 (USD MILLION)       326

TABLE 397            EUROPE: CELL CULTURE MARKET FOR MONOCLONAL ANTIBODY PRODUCTION,

BY COUNTRY, 2023–2030 (USD MILLION)               326

TABLE 398            ASIA PACIFIC: CELL CULTURE MARKET FOR MONOCLONAL ANTIBODY PRODUCTION, BY COUNTRY, 2023–2030 (USD MILLION)       327

TABLE 399            LATIN AMERICA: CELL CULTURE MARKET FOR MONOCLONAL ANTIBODY PRODUCTION, BY COUNTRY, 2023–2030 (USD MILLION)       327

TABLE 400            MIDDLE EAST: CELL CULTURE MARKET FOR MONOCLONAL ANTIBODY PRODUCTION, BY REGION, 2023–2030 (USD MILLION)       328

TABLE 401            GCC COUNTRIES: CELL CULTURE MARKET FOR MONOCLONAL ANTIBODY PRODUCTION, BY COUNTRY, 2023–2030 (USD MILLION)       328

TABLE 402            CELL CULTURE MARKET FOR VACCINE PRODUCTION, BY REGION,

2023–2030 (USD MILLION)            329

TABLE 403            NORTH AMERICA: CELL CULTURE MARKET FOR VACCINE PRODUCTION,

BY COUNTRY, 2023–2030 (USD MILLION)               330

TABLE 404            EUROPE: CELL CULTURE MARKET FOR VACCINE PRODUCTION, BY COUNTRY, 2023–2030 (USD MILLION)            330

TABLE 405            ASIA PACIFIC: CELL CULTURE MARKET FOR VACCINE PRODUCTION, BY COUNTRY, 2023–2030 (USD MILLION)            331

TABLE 406            LATIN AMERICA: CELL CULTURE MARKET FOR VACCINE PRODUCTION,

BY COUNTRY, 2023–2030 (USD MILLION)               331

TABLE 407            MIDDLE EAST: CELL CULTURE MARKET FOR VACCINE PRODUCTION, BY REGION, 2023–2030 (USD MILLION)                 332

TABLE 408            GCC COUNTRIES: CELL CULTURE MARKET FOR VACCINE PRODUCTION,

BY COUNTRY, 2023–2030 (USD MILLION)               332

TABLE 409            CELL CULTURE MARKET FOR OTHER THERAPEUTIC PROTEIN PRODUCTION,

BY REGION, 2023–2030 (USD MILLION)   333

TABLE 410            NORTH AMERICA: CELL CULTURE MARKET FOR OTHER THERAPEUTIC PROTEIN PRODUCTION, BY COUNTRY, 2023–2030 (USD MILLION)            333

TABLE 411            EUROPE: CELL CULTURE MARKET FOR OTHER THERAPEUTIC PROTEIN PRODUCTION, BY COUNTRY, 2023–2030 (USD MILLION)       334

TABLE 412            ASIA PACIFIC: CELL CULTURE MARKET FOR OTHER THERAPEUTIC PROTEIN PRODUCTION, BY COUNTRY, 2023–2030 (USD MILLION)            334

TABLE 413            LATIN AMERICA: CELL CULTURE MARKET FOR OTHER THERAPEUTIC PROTEIN PRODUCTION, BY COUNTRY, 2023–2030 (USD MILLION)            335

TABLE 414            MIDDLE EAST: CELL CULTURE MARKET FOR OTHER THERAPEUTIC PROTEIN PRODUCTION, BY REGION, 2023–2030 (USD MILLION)            335

TABLE 415            GCC COUNTRIES: CELL CULTURE MARKET FOR OTHER THERAPEUTIC PROTEIN PRODUCTION, BY COUNTRY, 2023–2030 (USD MILLION)            335

TABLE 416            CELL CULTURE MARKET FOR DIAGNOSTICS, BY REGION,

2023–2030 (USD MILLION)            336

TABLE 417            NORTH AMERICA: CELL CULTURE MARKET FOR DIAGNOSTICS, BY COUNTRY, 2023–2030 (USD MILLION)                 337

TABLE 418            EUROPE: CELL CULTURE MARKET FOR DIAGNOSTICS, BY COUNTRY,

2023–2030 (USD MILLION)            337

TABLE 419            ASIA PACIFIC: CELL CULTURE MARKET FOR DIAGNOSTICS, BY COUNTRY,

2023–2030 (USD MILLION)            338

TABLE 420            LATIN AMERICA: CELL CULTURE MARKET FOR DIAGNOSTI

CS, BY COUNTRY, 2023–2030 (USD MILLION)       338

TABLE 421            MIDDLE EAST: CELL CULTURE MARKET FOR DIAGNOSTICS, BY REGION,

2023–2030 (USD MILLION)            339

TABLE 422            GCC COUNTRIES: CELL CULTURE MARKET FOR DIAGNOSTICS, BY COUNTRY, 2023–2030 (USD MILLION)                 339

TABLE 423            CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY REGION, 2023–2030 (USD MILLION)       340

TABLE 424            NORTH AMERICA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2023–2030 (USD MILLION)     341

TABLE 425            EUROPE: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2023–2030 (USD MILLION)            341

TABLE 426            ASIA PACIFIC: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2023–2030 (USD MILLION)     342

TABLE 427            LATIN AMERICA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2023–2030 (USD MILLION)     342

TABLE 428            MIDDLE EAST: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY REGION, 2023–2030 (USD MILLION)            343

TABLE 429            GCC COUNTRIES: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2023–2030 (USD MILLION)     343

TABLE 430            CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2023–2030 (USD MILLION) 343

TABLE 431            CELL CULTURE MARKET FOR CELL & GENE THERAPY, BY REGION,

2023–2030 (USD MILLION)            345

TABLE 432            NORTH AMERICA: CELL CULTURE MARKET FOR CELL & GENE THERAPY,

BY COUNTRY, 2023–2030 (USD MILLION)               345

TABLE 433            EUROPE: CELL CULTURE MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2023–2030 (USD MILLION)                 346

TABLE 434            ASIA PACIFIC: CELL CULTURE MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2023–2030 (USD MILLION)            346

TABLE 435            LATIN AMERICA: CELL CULTURE MARKET FOR CELL & GENE THERAPY,

BY COUNTRY, 2023–2030 (USD MILLION)               347

TABLE 436            MIDDLE EAST: CELL CULTURE MARKET FOR CELL & GENE THERAPY, BY REGION, 2023–2030 (USD MILLION)                 347

TABLE 437            GCC COUNTRIES: CELL CULTURE MARKET FOR CELL & GENE THERAPY,

BY COUNTRY, 2023–2030 (USD MILLION)               347

TABLE 438            CELL CULTURE MARKET FOR OTHER TISSUE ENGINEERING & REGENERATIVE MEDICINE APPLICATIONS, BY REGION, 2023–2030 (USD MILLION)          348

TABLE 439            NORTH AMERICA: CELL CULTURE MARKET FOR OTHER TISSUE

ENGINEERING & REGENERATIVE MEDICINE APPLICATIONS, BY COUNTRY,

2023–2030 (USD MILLION)            349

TABLE 440            EUROPE: CELL CULTURE MARKET FOR OTHER TISSUE ENGINEERING & REGENERATIVE MEDICINE APPLICATIONS, BY COUNTRY,

2023–2030 (USD MILLION)            349

TABLE 441            ASIA PACIFIC: CELL CULTURE MARKET FOR OTHER TISSUE ENGINEERING & REGENERATIVE MEDICINE APPLICATIONS, BY COUNTRY,

2023–2030 (USD MILLION)            350

TABLE 442            LATIN AMERICA: CELL CULTURE MARKET FOR OTHER TISSUE ENGINEERING & REGENERATIVE MEDICINE APPLICATIONS, BY COUNTRY,

2023–2030 (USD MILLION)            350

TABLE 443            MIDDLE EAST: CELL CULTURE MARKET FOR OTHER TISSUE ENGINEERING & REGENERATIVE MEDICINE APPLICATIONS, BY REGION, 2023–2030 (USD MILLION)  351

TABLE 444            GCC COUNTRIES: CELL CULTURE MARKET FOR OTHER TISSUE ENGINEERING & REGENERATIVE MEDICINE APPLICATIONS, BY COUNTRY,

2023–2030 (USD MILLION)            351

TABLE 445            CELL CULTURE MARKET FOR DRUG SCREENING & DEVELOPMENT, BY REGION, 2023–2030 (USD MILLION)            352

TABLE 446            NORTH AMERICA: CELL CULTURE MARKET FOR DRUG SCREENING & DEVELOPMENT, BY COUNTRY, 2023–2030 (USD MILLION) 352

TABLE 447            EUROPE: CELL CULTURE MARKET FOR DRUG SCREENING & DEVELOPMENT,

BY COUNTRY, 2023–2030 (USD MILLION)               353

TABLE 448            ASIA PACIFIC: CELL CULTURE MARKET FOR DRUG SCREENING & DEVELOPMENT, BY COUNTRY, 2023–2030 (USD MILLION) 353

TABLE 449            LATIN AMERICA: CELL CULTURE MARKET FOR DRUG SCREENING & DEVELOPMENT, BY COUNTRY, 2023–2030 (USD MILLION) 354

TABLE 450            MIDDLE EAST: CELL CULTURE MARKET FOR DRUG SCREENING & DEVELOPMENT, BY REGION, 2023–2030 (USD MILLION) 354

TABLE 451            GCC COUNTRIES: CELL CULTURE MARKET FOR DRUG SCREENING & DEVELOPMENT, BY COUNTRY, 2023–2030 (USD MILLION) 354

TABLE 452            CELL CULTURE MARKET FOR OTHER APPLICATIONS, BY REGION,

2023–2030 (USD MILLION)            355

TABLE 453            NORTH AMERICA: CELL CULTURE MARKET FOR OTHER APPLICATIONS,

BY COUNTRY, 2023–2030 (USD MILLION)               356

TABLE 454            EUROPE: CELL CULTURE MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)                 356

TABLE 455            ASIA PACIFIC: CELL CULTURE MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)            357

TABLE 456            LATIN AMERICA: CELL CULTURE MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)            357

TABLE 457            MIDDLE EAST: CELL CULTURE MARKET FOR OTHER APPLICATIONS, BY REGION, 2023–2030 (USD MILLION)                 358

TABLE 458            GCC COUNTRIES: CELL CULTURE MARKET FOR OTHER APPLICATIONS,

BY COUNTRY, 2023–2030 (USD MILLION)               358

TABLE 459            CELL CULTURE MARKET, BY END USER, 2023–2030 (USD MILLION)       360

TABLE 460            RECENT DEVELOPMENTS IN PHARMA & BIOTECH SECTOR, 2021–2024      361

TABLE 461            CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023–2030 (USD MILLION)          362

TABLE 462            NORTH AMERICA: CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)     362

TABLE 463            EUROPE: CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)     363

TABLE 464            ASIA PACIFIC: CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)     363

TABLE 465            LATIN AMERICA: CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)     364

TABLE 466            MIDDLE EAST: CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023–2030 (USD MILLION)          364

TABLE 467            GCC COUNTRIES: CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)     364

TABLE 468            CELL CULTURE MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES,

BY REGION, 2023–2030 (USD MILLION)   366

TABLE 469            NORTH AMERICA: CELL CULTURE MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)            366

TABLE 470            EUROPE: CELL CULTURE MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)            367

TABLE 471            ASIA PACIFIC: CELL CULTURE MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)            367

TABLE 472            LATIN AMERICA: CELL CULTURE MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)            368

TABLE 473            MIDDLE EAST: CELL CULTURE MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2023–2030 (USD MILLION)       368

TABLE 474            GCC COUNTRIES: CELL CULTURE MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)            368

TABLE 475            CELL CULTURE MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2023–2030 (USD MILLION)                 369

TABLE 476            NORTH AMERICA: CELL CULTURE MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION) 370

TABLE 477            EUROPE: CELL CULTURE MARKET FOR RESEARCH & ACADEMIC INSTITUTES,

BY COUNTRY, 2023–2030 (USD MILLION)               370

TABLE 478            ASIA PACIFIC: CELL CULTURE MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION) 371

TABLE 479            LATIN AMERICA: CELL CULTURE MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION) 371

TABLE 480            MIDDLE EAST: CELL CULTURE MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2023–2030 (USD MILLION) 372

TABLE 481            GCC COUNTRIES: CELL CULTURE MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION) 372

TABLE 482            CELL CULTURE MARKET FOR OTHER END USERS, BY REGION,

2023–2030 (USD MILLION)            373

TABLE 483            NORTH AMERICA: CELL CULTURE MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION)                 374

TABLE 484            EUROPE: CELL CULTURE MARKET FOR OTHER END USERS, BY COUNTRY,

2023–2030 (USD MILLION)            374

TABLE 485            ASIA PACIFIC: CELL CULTURE MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION)                 375

TABLE 486            LATIN AMERICA: CELL CULTURE MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION)                 375

TABLE 487            MIDDLE EAST: CELL CULTURE MARKET FOR OTHER END USERS, BY REGION, 2023–2030 (USD MILLION)                 376

TABLE 488            GCC COUNTRIES: CELL CULTURE MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION)                 376

TABLE 489            CELL CULTURE MARKET, BY REGION, 2023–2030 (USD MILLION) 378

TABLE 490            NORTH AMERICA: CELL CULTURE MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            380

TABLE 491            NORTH AMERICA: CELL CULTURE MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            381

TABLE 492            NORTH AMERICA: CELL CULTURE CONSUMABLES MARKET, BY TYPE,

2023–2030 (USD MILLION)            381

TABLE 493            NORTH AMERICA: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)                 381

TABLE 494            NORTH AMERICA: CELL CULTURE MEDIA MARKET, BY TYPE,

2023–2030 (USD MILLION)            382

TABLE 495            NORTH AMERICA: CELL CULTURE REAGENTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            382

TABLE 496            NORTH AMERICA: CELL CULTURE SERA MARKET, BY TYPE,

2023–2030 (USD MILLION)            383

TABLE 497            NORTH AMERICA: CELL CULTURE VESSELS MARKET, BY TYPE,

2023–2030 (USD MILLION)            383

TABLE 498            NORTH AMERICA: CELL CULTURE EQUIPMENT MARKET, BY TYPE,

2023–2030 (USD MILLION)            383

TABLE 499            NORTH AMERICA: CELL CULTURE MARKET FOR BIOREACTORS, BY TYPE,

2023–2030 (USD MILLION)            384

TABLE 500            NORTH AMERICA: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)                 384

TABLE 501            NORTH AMERICA: CELL CULTURE MARKET FOR OTHER EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)                 385

TABLE 502            NORTH AMERICA: CELL CULTURE MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            385

TABLE 503            NORTH AMERICA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2023–2030 (USD MILLION)            386

TABLE 504            NORTH AMERICA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2023–2030 (USD MILLION)            386

TABLE 505            NORTH AMERICA: CELL CULTURE MARKET, BY END USER,

2023–2030 (USD MILLION)          387

TABLE 506            INDICATIVE LIST OF CELL AND GENE THERAPIES APPROVED IN 2024-2024        387

TABLE 507            US: CELL CULTURE MARKET, BY PRODUCT, 2023–2030 (USD MILLION)            388

TABLE 508            US: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)                388

TABLE 509            US: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            389

TABLE 510            US: CELL CULTURE MEDIA MARKET, BY TYPE, 2023–2030 (USD MILLION)            389

TABLE 511            US: CELL CULTURE REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)                390

TABLE 512            US: CELL CULTURE SERA MARKET, BY TYPE, 2023–2030 (USD MILLION)            390

TABLE 513            US: CELL CULTURE VESSELS MARKET, BY TYPE, 2023–2030 (USD MILLION)            391

TABLE 514            US: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2023–2030 (USD MILLION)                391

TABLE 515            US: CELL CULTURE MARKET FOR BIOREACTORS, BY TYPE,

2023–2030 (USD MILLION)            391

TABLE 516            US: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY TYPE,

2023–2030 (USD MILLION)            392

TABLE 517            US: CELL CULTURE MARKET FOR OTHER EQUIPMENT, BY TYPE,

2023–2030 (USD MILLION)            392

TABLE 518            US: CELL CULTURE MARKET, BY APPLICATION, 2023–2030 (USD MILLION)            393

TABLE 519            US: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2023–2030 (USD MILLION)            393

TABLE 520            US: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2023–2030 (USD MILLION) 394

TABLE 521            US: CELL CULTURE MARKET, BY END USER, 2023–2030 (USD MILLION)            394

TABLE 522            CANADA: CELL CULTURE MARKET, BY PRODUCT, 2023–2030 (USD MILLION)     395

TABLE 523            CANADA: CELL CULTURE CONSUMABLES MARKET, BY TYPE,

2023–2030 (USD MILLION)            396

TABLE 524            CANADA: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET,

BY TYPE, 2023–2030 (USD MILLION)         396

TABLE 525            CANADA: CELL CULTURE MEDIA MARKET, BY TYPE, 2023–2030 (USD MILLION)                396

TABLE 526            CANADA: CELL CULTURE REAGENTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            397

TABLE 527            CANADA: CELL CULTURE SERA MARKET, BY TYPE, 2023–2030 (USD MILLION)                397

TABLE 528            CANADA: CELL CULTURE VESSELS MARKET, BY TYPE, 2023–2030 (USD MILLION)                398

TABLE 529          CANADA: CELL CULTURE EQUIPMENT MARKET, BY TYPE,

2023–2030 (USD MILLION)            398

TABLE 530            CANADA: CELL CULTURE MARKET FOR BIOREACTORS, BY TYPE,

2023–2030 (USD MILLION)            398

TABLE 531            CANADA: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY TYPE,

2023–2030 (USD MILLION)            399

TABLE 532            CANADA: CELL CULTURE MARKET FOR OTHER EQUIPMENT, BY TYPE,

2023–2030 (USD MILLION)          399

TABLE 533            CANADA: CELL CULTURE MARKET, BY APPLICATION, 2023–2030 (USD MILLION)              400

TABLE 534            CANADA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2023–2030 (USD MILLION)            400

TABLE 535            CANADA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2023–2030 (USD MILLION) 401

TABLE 536            CANADA: CELL CULTURE MARKET, BY END USER, 2023–2030 (USD MILLION)                401

TABLE 537            EUROPE: CELL CULTURE MARKET, BY COUNTRY, 2023–2030 (USD MILLION)     403

TABLE 538            EUROPE: CELL CULTURE MARKET, BY PRODUCT, 2023–2030 (USD MILLION)     403

TABLE 539            EUROPE: CELL CULTURE CONSUMABLES MARKET, BY TYPE,

2023–2030 (USD MILLION)            403

TABLE 540            EUROPE: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET,

BY TYPE, 2023–2030 (USD MILLION)         404

TABLE 541            EUROPE: CELL CULTURE MEDIA MARKET, BY TYPE, 2023–2030 (USD MILLION)                404

TABLE 542            EUROPE: CELL CULTURE REAGENTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            405

TABLE 543            EUROPE: CELL CULTURE SERA MARKET, BY TYPE, 2023–2030 (USD MILLION)                405

TABLE 544            EUROPE: CELL CULTURE VESSELS MARKET, BY TYPE, 2023–2030 (USD MILLION)                406

TABLE 545            EUROPE: CELL CULTURE EQUIPMENT MARKET, BY TYPE,

2023–2030 (USD MILLION)            406

TABLE 546            EUROPE: CELL CULTURE MARKET FOR BIOREACTORS, BY TYPE,

2023–2030 (USD MILLION)            406

TABLE 547            EUROPE: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY TYPE,

2023–2030 (USD MILLION)            407

TABLE 548            EUROPE: CELL CULTURE MARKET FOR OTHER EQUIPMENT, BY TYPE,

2023–2030 (USD MILLION)            407

TABLE 549            EUROPE: CELL CULTURE MARKET, BY APPLICATION, 2023–2030 (USD MILLION)              408

TABLE 550            EUROPE: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION,

BY TYPE, 2023–2030 (USD MILLION)         408

TABLE 551            EUROPE: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2023–2030 (USD MILLION) 409

TABLE 552            EUROPE: CELL CULTURE MARKET, BY END USER, 2023–2030 (USD MILLION)                409

TABLE 553            GERMANY: CELL CULTURE MARKET, BY PRODUCT, 2023–2030 (USD MILLION)     410

TABLE 554            GERMANY: CELL CULTURE CONSUMABLES MARKET, BY TYPE,

2023–2030 (USD MILLION)            410

TABLE 555            GERMANY: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET,

BY TYPE, 2023–2030 (USD MILLION)         411

TABLE 556            GERMANY: CELL CULTURE MEDIA MARKET, BY TYPE, 2023–2030 (USD MILLION)                411

TABLE 557          GERMANY: CELL CULTURE REAGENTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            412

TABLE 558            GERMANY: CELL CULTURE SERA MARKET, BY TYPE, 2023–2030 (USD MILLION)                412

TABLE 559            GERMANY: CELL CULTURE VESSELS MARKET, BY TYPE,

2023–2030 (USD MILLION)            413

TABLE 560            GERMANY: CELL CULTURE EQUIPMENT MARKET, BY TYPE,

2023–2030 (USD MILLION)            413

TABLE 561            GERMANY: CELL CULTURE MARKET FOR BIOREACTORS, BY TYPE,

2023–2030 (USD MILLION)            413

TABLE 562            GERMANY: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY TYPE,

2023–2030 (USD MILLION)            414

TABLE 563            GERMANY: CELL CULTURE MARKET FOR OTHER EQUIPMENT, BY TYPE,

2023–2030 (USD MILLION)            414

TABLE 564            GERMANY: CELL CULTURE MARKET, BY APPLICATION, 2023–2030 (USD MILLION)              415

TABLE 565            GERMANY: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION,

BY TYPE, 2023–2030 (USD MILLION)         415

TABLE 566            GERMANY: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2023–2030 (USD MILLION)            416

TABLE 567            GERMANY: CELL CULTURE MARKET, BY END USER, 2023–2030 (USD MILLION)                416

TABLE 568            UK: CELL CULTURE MARKET, BY PRODUCT, 2023–2030 (USD MILLION)            417

TABLE 569            UK: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)         417

TABLE 570            UK: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            418

TABLE 571            UK: CELL CULTURE MEDIA MARKET, BY TYPE, 2023–2030 (USD MILLION)            418

TABLE 572            UK: CELL CULTURE REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)                419

TABLE 573            UK: CELL CULTURE SERA MARKET, BY TYPE, 2023–2030 (USD MILLION)            419

TABLE 574            UK: CELL CULTURE VESSELS MARKET, BY TYPE, 2023–2030 (USD MILLION)            420

TABLE 575            UK: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2023–2030 (USD MILLION)                420

TABLE 576            UK: CELL CULTURE MARKET FOR BIOREACTORS, BY TYPE,

2023–2030 (USD MILLION)            420

TABLE 577            UK: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY TYPE,

2023–2030 (USD MILLION)            421

TABLE 578            UK: CELL CULTURE MARKET FOR OTHER EQUIPMENT, BY TYPE,

2023–2030 (USD MILLION)            421

TABLE 579            UK: CELL CULTURE MARKET, BY APPLICATION, 2023–2030 (USD MILLION)            422

TABLE 580            UK: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2023–2030 (USD MILLION)            422

TABLE 581            UK: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2023–2030 (USD MILLION) 423

TABLE 582            UK: CELL CULTURE MARKET, BY END USER, 2023–2030 (USD MILLION)            423

TABLE 583            FRANCE: CELL CULTURE MARKET, BY PRODUCT, 2023–2030 (USD MILLION)     424

TABLE 584            FRANCE: CELL CULTURE CONSUMABLES MARKET, BY TYPE,

2023–2030 (USD MILLION)            424

TABLE 585            FRANCE: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET,

BY TYPE, 2023–2030 (USD MILLION)         425

TABLE 586            FRANCE: CELL CULTURE MEDIA MARKET, BY TYPE, 2023–2030 (USD MILLION)                425

TABLE 587            FRANCE: CELL CULTURE REAGENTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            426

TABLE 588            FRANCE: CELL CULTURE SERA MARKET, BY TYPE, 2023–2030 (USD MILLION)                426

TABLE 589            FRANCE: CELL CULTURE VESSELS MARKET, BY TYPE, 2023–2030 (USD MILLION)                427

TABLE 590            FRANCE: CELL CULTURE EQUIPMENT MARKET, BY TYPE,

2023–2030 (USD MILLION)            427

TABLE 591            FRANCE: CELL CULTURE MARKET FOR BIOREACTORS, BY TYPE,

2023–2030 (USD MILLION)            427

TABLE 592            FRANCE: CELL CULTURE MARKET FOR STORAGE EQUIPMENT,

BY TYPE, 2023–2030 (USD MILLION)         428

TABLE 593            FRANCE: CELL CULTURE MARKET FOR OTHER EQUIPMENT,

BY TYPE, 2023–2030 (USD MILLION)         428

TABLE 594            FRANCE: CELL CULTURE MARKET, BY APPLICATION, 2023–2030 (USD MILLION)              429

TABLE 595            FRANCE: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION,

BY TYPE, 2023–2030 (USD MILLION)         429

TABLE 596            FRANCE: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2023–2030 (USD MILLION) 430

TABLE 597            FRANCE: CELL CULTURE MARKET, BY END USER, 2023–2030 (USD MILLION)                430

TABLE 598            ITALY: CELL CULTURE MARKET, BY PRODUCT, 2023–2030 (USD MILLION)            431

TABLE 599          ITALY: CELL CULTURE CONSUMABLES MARKET, BY TYPE,

2023–2030 (USD MILLION)            432

TABLE 600            ITALY: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET,

BY TYPE, 2023–2030 (USD MILLION)         432

TABLE 601            ITALY: CELL CULTURE MEDIA MARKET, BY TYPE, 2023–2030 (USD MILLION)                432

TABLE 602            ITALY: CELL CULTURE REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)                433

TABLE 603            ITALY: CELL CULTURE SERA MARKET, BY TYPE, 2023–2030 (USD MILLION)            433

TABLE 604            ITALY: CELL CULTURE VESSELS MARKET, BY TYPE, 2023–2030 (USD MILLION)                434

TABLE 605            ITALY: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2023–2030 (USD MILLION)         434

TABLE 606            ITALY: CELL CULTURE MARKET FOR BIOREACTORS, BY TYPE,

2023–2030 (USD MILLION)            434

TABLE 607            ITALY: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY TYPE,

2023–2030 (USD MILLION)            435

TABLE 608            ITALY: CELL CULTURE MARKET FOR OTHER EQUIPMENT, BY TYPE,

2023–2030 (USD MILLION)            435

TABLE 609            ITALY: CELL CULTURE MARKET, BY APPLICATION, 2023–2030 (USD MILLION)              436

TABLE 610            ITALY: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2023–2030 (USD MILLION)            436

TABLE 611            ITALY: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2023–2030 (USD MILLION) 437

TABLE 612            ITALY: CELL CULTURE MARKET, BY END USER, 2023–2030 (USD MILLION)            437

TABLE 613            SPAIN: CELL CULTURE MARKET, BY PRODUCT, 2023–2030 (USD MILLION)            438

TABLE 614          SPAIN: CELL CULTURE CONSUMABLES MARKET, BY TYPE,

2023–2030 (USD MILLION)            438

TABLE 615            SPAIN: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET,

BY TYPE, 2023–2030 (USD MILLION)         439

TABLE 616            SPAIN: CELL CULTURE MEDIA MARKET, BY TYPE, 2023–2030 (USD MILLION)                439

TABLE 617            SPAIN: CELL CULTURE REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)                440

TABLE 618            SPAIN: CELL CULTURE SERA MARKET, BY TYPE, 2023–2030 (USD MILLION)            440

TABLE 619            SPAIN: CELL CULTURE VESSELS MARKET, BY TYPE, 2023–2030 (USD MILLION)                441

TABLE 620            SPAIN: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2023–2030 (USD MILLION)         441

TABLE 621            SPAIN: CELL CULTURE MARKET FOR BIOREACTORS, BY TYPE,

2023–2030 (USD MILLION)            441

TABLE 622            SPAIN: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY TYPE,

2023–2030 (USD MILLION)            442

TABLE 623            SPAIN: CELL CULTURE MARKET FOR OTHER EQUIPMENT, BY TYPE,

2023–2030 (USD MILLION)            442

TABLE 624            SPAIN: CELL CULTURE MARKET, BY APPLICATION, 2023–2030 (USD MILLION)              443

TABLE 625            SPAIN: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION,

BY TYPE, 2023–2030 (USD MILLION)         443

TABLE 626            SPAIN: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2023–2030 (USD MILLION) 444

TABLE 627            SPAIN: CELL CULTURE MARKET, BY END USER, 2023–2030 (USD MILLION)            444

TABLE 628            REST OF EUROPE: CELL CULTURE MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            445

TABLE 629            REST OF EUROPE: CELL CULTURE CONSUMABLES MARKET, BY TYPE,

2023–2030 (USD MILLION)            445

TABLE 630            REST OF EUROPE: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET,

BY TYPE, 2023–2030 (USD MILLION)         446

TABLE 631            REST OF EUROPE: CELL CULTURE MEDIA MARKET, BY TYPE,

2023–2030 (USD MILLION)            446

TABLE 632            REST OF EUROPE: CELL CULTURE REAGENTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            447

TABLE 633            REST OF EUROPE: CELL CULTURE SERA MARKET, BY TYPE,

2023–2030 (USD MILLION)            447

TABLE 634            REST OF EUROPE: CELL CULTURE VESSELS MARKET, BY TYPE,

2023–2030 (USD MILLION)            448

TABLE 635            REST OF EUROPE: CELL CULTURE EQUIPMENT MARKET, BY TYPE,

2023–2030 (USD MILLION)            448

TABLE 636            REST OF EUROPE: CELL CULTURE MARKET FOR BIOREACTORS, BY TYPE,

2023–2030 (USD MILLION)            449

TABLE 637            REST OF EUROPE: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)                 449

TABLE 638            REST OF EUROPE: CELL CULTURE MARKET FOR OTHER EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)                 450

TABLE 639            REST OF EUROPE: CELL CULTURE MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            450

TABLE 640            REST OF EUROPE: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2023–2030 (USD MILLION)            451

TABLE 641            REST OF EUROPE: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2023–2030 (USD MILLION)            451

TABLE 642            REST OF EUROPE: CELL CULTURE MARKET, BY END USER,

2023–2030 (USD MILLION)            452

TABLE 643            ASIA PACIFIC: CELL CULTURE MARKET, BY COUNTRY, 2023–2030 (USD MILLION)     455

TABLE 644            ASIA PACIFIC: CELL CULTURE MARKET, BY PRODUCT, 2023–2030 (USD MILLION)     455

TABLE 645            ASIA PACIFIC: CELL CULTURE CONSUMABLES MARKET, BY TYPE,

2023–2030 (USD MILLION)          455

TABLE 646            ASIA PACIFIC: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)                 456

TABLE 647            ASIA PACIFIC: CELL CULTURE MEDIA MARKET, BY TYPE,

2023–2030 (USD MILLION)            456

TABLE 648            ASIA PACIFIC: CELL CULTURE REAGENTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            457

TABLE 649            ASIA PACIFIC: CELL CULTURE SERA MARKET, BY TYPE, 2023–2030 (USD MILLION)                457

TABLE 650          ASIA PACIFIC: CELL CULTURE VESSELS MARKET, BY TYPE,

2023–2030 (USD MILLION)            458

TABLE 651            ASIA PACIFIC: CELL CULTURE EQUIPMENT MARKET, BY TYPE,

2023–2030 (USD MILLION)            458

TABLE 652            ASIA PACIFIC: CELL CULTURE MARKET FOR BIOREACTORS, BY TYPE,

2023–2030 (USD MILLION)            458

TABLE 653            ASIA PACIFIC: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)                 459

TABLE 654            ASIA PACIFIC: CELL CULTURE MARKET FOR OTHER EQUIPMENT, BY TYPE,

2023–2030 (USD MILLION)            459

TABLE 655            ASIA PACIFIC: CELL CULTURE MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            460

TABLE 656            ASIA PACIFIC: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2023–2030 (USD MILLION)            460

TABLE 657            ASIA PACIFIC: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2023–2030 (USD MILLION)            461

TABLE 658            ASIA PACIFIC: CELL CULTURE MARKET, BY END USER, 2023–2030 (USD MILLION)                461

TABLE 659            CHINA: CELL CULTURE MARKET, BY PRODUCT, 2023–2030 (USD MILLION)            462

TABLE 660            CHINA: CELL CULTURE CONSUMABLES MARKET, BY TYPE,

2023–2030 (USD MILLION)            463

TABLE 661            CHINA: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET,

BY TYPE, 2023–2030 (USD MILLION)         463

TABLE 662            CHINA: CELL CULTURE MEDIA MARKET, BY TYPE, 2023–2030 (USD MILLION)                463

TABLE 663            CHINA: CELL CULTURE REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)                464

TABLE 664            CHINA: CELL CULTURE SERA MARKET, BY TYPE, 2023–2030 (USD MILLION)            464

TABLE 665            CHINA: CELL CULTURE VESSELS MARKET, BY TYPE, 2023–2030 (USD MILLION)                465

TABLE 666            CHINA: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2023–2030 (USD MILLION)         465

TABLE 667            CHINA: CELL CULTURE MARKET FOR BIOREACTORS, BY TYPE,

2023–2030 (USD MILLION)            465

TABLE 668            CHINA: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY TYPE,

2023–2030 (USD MILLION)            466

TABLE 669            CHINA: CELL CULTURE MARKET FOR OTHER EQUIPMENT, BY TYPE,

2023–2030 (USD MILLION)            466

TABLE 670            CHINA: CELL CULTURE MARKET, BY APPLICATION, 2023–2030 (USD MILLION)              467

TABLE 671            CHINA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2023–2030 (USD MILLION)            467

TABLE 672            CHINA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2023–2030 (USD MILLION) 468

TABLE 673            CHINA: CELL CULTURE MARKET, BY END USER, 2023–2030 (USD MILLION)            468

TABLE 674            JAPAN: CELL CULTURE MARKET, BY PRODUCT, 2023–2030 (USD MILLION)            470

TABLE 675            JAPAN: CELL CULTURE CONSUMABLES MARKET, BY TYPE,

2023–2030 (USD MILLION)            470

TABLE 676            JAPAN: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET,

BY TYPE, 2023–2030 (USD MILLION)         470

TABLE 677            JAPAN: CELL CULTURE MEDIA MARKET, BY TYPE, 2023–2030 (USD MILLION)                471

TABLE 678            JAPAN: CELL CULTURE REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)                471

TABLE 679            JAPAN: CELL CULTURE SERA MARKET, BY TYPE, 2023–2030 (USD MILLION)            472

TABLE 680            JAPAN: CELL CULTURE VESSELS MARKET, BY TYPE, 2023–2030 (USD MILLION)                472

TABLE 681            JAPAN: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2023–2030 (USD MILLION)         472

TABLE 682            JAPAN: CELL CULTURE MARKET FOR BIOREACTORS, BY TYPE,

2023–2030 (USD MILLION)            473

TABLE 683            JAPAN: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY TYPE,

2023–2030 (USD MILLION)            473

TABLE 684            JAPAN: CELL CULTURE MARKET FOR OTHER EQUIPMENT, BY TYPE,

2023–2030 (USD MILLION)            474

TABLE 685            JAPAN: CELL CULTURE MARKET, BY APPLICATION, 2023–2030 (USD MILLION)              474

TABLE 686            JAPAN: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2023–2030 (USD MILLION)            475

TABLE 687            JAPAN: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2023–2030 (USD MILLION) 475

TABLE 688            JAPAN: CELL CULTURE MARKET, BY END USER, 2023–2030 (USD MILLION)            476

TABLE 689            INDIA: CELL CULTURE MARKET, BY PRODUCT, 2023–2030 (USD MILLION)            477

TABLE 690          INDIA: CELL CULTURE CONSUMABLES MARKET, BY TYPE,

2023–2030 (USD MILLION)            477

TABLE 691            INDIA: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            477

TABLE 692            INDIA: CELL CULTURE MEDIA MARKET, BY TYPE, 2023–2030 (USD MILLION)                478

TABLE 693            INDIA: CELL CULTURE REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)                478

TABLE 694            INDIA: CELL CULTURE SERA MARKET, BY TYPE, 2023–2030 (USD MILLION)            479

TABLE 695            INDIA: CELL CULTURE VESSELS MARKET, BY TYPE, 2023–2030 (USD MILLION)                479

TABLE 696            INDIA: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2023–2030 (USD MILLION)         479

TABLE 697            INDIA: CELL CULTURE MARKET FOR BIOREACTORS, BY TYPE,

2023–2030 (USD MILLION)            480

TABLE 698            INDIA: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY TYPE,

2023–2030 (USD MILLION)            480

TABLE 699            INDIA: CELL CULTURE MARKET FOR OTHER EQUIPMENT, BY TYPE,

2023–2030 (USD MILLION)            481

TABLE 700            INDIA: CELL CULTURE MARKET, BY APPLICATION, 2023–2030 (USD MILLION)              481

TABLE 701            INDIA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2023–2030 (USD MILLION)            482

TABLE 702            INDIA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2023–2030 (USD MILLION) 482

TABLE 703            INDIA: CELL CULTURE MARKET, BY END USER, 2023–2030 (USD MILLION)            483

TABLE 704            SOUTH KOREA: CELL CULTURE MARKET, BY PRODUCT, 2023–2030 (USD MILLION)     484

TABLE 705            SOUTH KOREA: CELL CULTURE CONSUMABLES MARKET, BY TYPE,

2023–2030 (USD MILLION)            484

TABLE 706            SOUTH KOREA: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)                 484

TABLE 707          SOUTH KOREA: CELL CULTURE MEDIA MARKET, BY TYPE,

2023–2030 (USD MILLION)            485

TABLE 708            SOUTH KOREA: CELL CULTURE REAGENTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            485

TABLE 709            SOUTH KOREA: CELL CULTURE SERA MARKET, BY TYPE,

2023–2030 (USD MILLION)            486

TABLE 710            SOUTH KOREA: CELL CULTURE VESSELS MARKET, BY TYPE,

2023–2030 (USD MILLION)            486

TABLE 711            SOUTH KOREA: CELL CULTURE EQUIPMENT MARKET, BY TYPE,

2023–2030 (USD MILLION)            486

TABLE 712            SOUTH KOREA: CELL CULTURE MARKET FOR BIOREACTORS, BY TYPE,

2023–2030 (USD MILLION)            487

TABLE 713            SOUTH KOREA: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)                 487

TABLE 714            SOUTH KOREA: CELL CULTURE MARKET FOR OTHER EQUIPMENT, BY TYPE,

2023–2030 (USD MILLION)          488

TABLE 715            SOUTH KOREA: CELL CULTURE MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            488

TABLE 716            SOUTH KOREA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2023–2030 (USD MILLION)            489

TABLE 717            SOUTH KOREA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2023–2030 (USD MILLION)            489

TABLE 718            SOUTH KOREA: CELL CULTURE MARKET, BY END USER,

2023–2030 (USD MILLION)            490

TABLE 719            AUSTRALIA: CELL CULTURE MARKET, BY PRODUCT, 2023–2030 (USD MILLION)     490

TABLE 720            AUSTRALIA: CELL CULTURE CONSUMABLES MARKET, BY TYPE,

2023–2030 (USD MILLION)            491

TABLE 721            AUSTRALIA: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)                 491

TABLE 722            AUSTRALIA: CELL CULTURE MEDIA MARKET, BY TYPE, 2023–2030 (USD MILLION)         492

TABLE 723            AUSTRALIA: CELL CULTURE REAGENTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            492

TABLE 724            AUSTRALIA: CELL CULTURE SERA MARKET, BY TYPE, 2023–2030 (USD MILLION)                493

TABLE 725            AUSTRALIA: CELL CULTURE VESSELS MARKET, BY TYPE,

2023–2030 (USD MILLION)            493

TABLE 726            AUSTRALIA: CELL CULTURE EQUIPMENT MARKET, BY TYPE,

2023–2030 (USD MILLION)            493

TABLE 727            AUSTRALIA: CELL CULTURE MARKET FOR BIOREACTORS, BY TYPE,

2023–2030 (USD MILLION)            494

TABLE 728            AUSTRALIA: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY TYPE,

2023–2030 (USD MILLION)            494

TABLE 729            AUSTRALIA: CELL CULTURE MARKET FOR OTHER EQUIPMENT, BY TYPE,

2023–2030 (USD MILLION)            495

TABLE 730            AUSTRALIA: CELL CULTURE MARKET, BY APPLICATION, 2023–2030 (USD MILLION)              495

TABLE 731            AUSTRALIA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION,

BY TYPE, 2023–2030 (USD MILLION)         496

TABLE 732            AUSTRALIA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2023–2030 (USD MILLION)            496

TABLE 733            AUSTRALIA: CELL CULTURE MARKET, BY END USER, 2023–2030 (USD MILLION)                497

TABLE 734          REST OF ASIA PACIFIC: CELL CULTURE MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            497

TABLE 735            REST OF ASIA PACIFIC: CELL CULTURE CONSUMABLES MARKET,

BY TYPE, 2023–2030 (USD MILLION)         498

TABLE 736            REST OF ASIA PACIFIC: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET,

BY TYPE, 2023–2030 (USD MILLION)         498

TABLE 737            REST OF ASIA PACIFIC: CELL CULTURE MEDIA MARKET, BY TYPE,

2023–2030 (USD MILLION)            499

TABLE 738            REST OF ASIA PACIFIC: CELL CULTURE REAGENTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            499

TABLE 739            REST OF ASIA PACIFIC: CELL CULTURE SERA MARKET, BY TYPE,

2023–2030 (USD MILLION)            500

TABLE 740            REST OF ASIA PACIFIC: CELL CULTURE VESSELS MARKET, BY TYPE,

2023–2030 (USD MILLION)            500

TABLE 741            REST OF ASIA PACIFIC: CELL CULTURE EQUIPMENT MARKET, BY TYPE,

2023–2030 (USD MILLION)            501

TABLE 742            REST OF ASIA PACIFIC: CELL CULTURE MARKET FOR BIOREACTORS,

BY TYPE, 2023–2030 (USD MILLION)         501

TABLE 743            REST OF ASIA PACIFIC: CELL CULTURE MARKET FOR STORAGE EQUIPMENT,

BY TYPE, 2023–2030 (USD MILLION)         501

TABLE 744            REST OF ASIA PACIFIC: CELL CULTURE MARKET FOR OTHER EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)                 502

TABLE 745          REST OF ASIA PACIFIC: CELL CULTURE MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            502

TABLE 746            REST OF ASIA PACIFIC: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2023–2030 (USD MILLION) 503

TABLE 747            REST OF ASIA PACIFIC: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2023–2030 (USD MILLION)                503

TABLE 748          REST OF ASIA PACIFIC: CELL CULTURE MARKET, BY END USER,

2023–2030 (USD MILLION)            504

TABLE 749            LATIN AMERICA: CELL CULTURE MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            505

TABLE 750            LATIN AMERICA: CELL CULTURE MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            505

TABLE 751            LATIN AMERICA: CELL CULTURE CONSUMABLES MARKET, BY TYPE,

2023–2030 (USD MILLION)            506

TABLE 752            LATIN AMERICA: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)                 506

TABLE 753            LATIN AMERICA: CELL CULTURE MEDIA MARKET, BY TYPE,

2023–2030 (USD MILLION)            506

TABLE 754            LATIN AMERICA: CELL CULTURE REAGENTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            507

TABLE 755            LATIN AMERICA: CELL CULTURE SERA MARKET, BY TYPE,

2023–2030 (USD MILLION)            507

TABLE 756            LATIN AMERICA: CELL CULTURE VESSELS MARKET, BY TYPE,

2023–2030 (USD MILLION)            508

TABLE 757            LATIN AMERICA: CELL CULTURE EQUIPMENT MARKET, BY TYPE,

2023–2030 (USD MILLION)          508

TABLE 758            LATIN AMERICA: CELL CULTURE MARKET FOR BIOREACTORS, BY TYPE,

2023–2030 (USD MILLION)            508

TABLE 759            LATIN AMERICA: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)                 509

TABLE 760            LATIN AMERICA: CELL CULTURE MARKET FOR OTHER EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)                 509

TABLE 761            LATIN AMERICA: CELL CULTURE MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            510

TABLE 762            LATIN AMERICA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2023–2030 (USD MILLION)            510

TABLE 763            LATIN AMERICA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2023–2030 (USD MILLION)            511

TABLE 764            LATIN AMERICA: CELL CULTURE MARKET, BY END USER,

2023–2030 (USD MILLION)            511

TABLE 765            BRAZIL: CELL CULTURE MARKET, BY PRODUCT, 2023–2030 (USD MILLION)            512

TABLE 766            BRAZIL: CELL CULTURE CONSUMABLES MARKET, BY TYPE,

2023–2030 (USD MILLION)            513

TABLE 767            BRAZIL: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            513

TABLE 768            BRAZIL: CELL CULTURE MEDIA MARKET, BY TYPE, 2023–2030 (USD MILLION)                513

TABLE 769            BRAZIL: CELL CULTURE REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)         514

TABLE 770          BRAZIL: CELL CULTURE SERA MARKET, BY TYPE, 2023–2030 (USD MILLION)            514

TABLE 771            BRAZIL: CELL CULTURE VESSELS MARKET, BY TYPE, 2023–2030 (USD MILLION)                515

TABLE 772            BRAZIL: CELL CULTURE EQUIPMENT MARKET, BY TYPE,

2023–2030 (USD MILLION)            515

TABLE 773            BRAZIL: CELL CULTURE MARKET FOR BIOREACTORS, BY TYPE,

2023–2030 (USD MILLION)            515

TABLE 774            BRAZIL: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY TYPE,

2023–2030 (USD MILLION)          516

TABLE 775            BRAZIL: CELL CULTURE MARKET FOR OTHER EQUIPMENT, BY TYPE,

2023–2030 (USD MILLION)            516

TABLE 776            BRAZIL: CELL CULTURE MARKET, BY APPLICATION, 2023–2030 (USD MILLION)              517

TABLE 777            BRAZIL: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION,

BY TYPE, 2023–2030 (USD MILLION)         517

TABLE 778            BRAZIL: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2023–2030 (USD MILLION) 518

TABLE 779            BRAZIL: CELL CULTURE MARKET, BY END USER, 2023–2030 (USD MILLION)            518

TABLE 780            MEXICO: CELL CULTURE MARKET, BY PRODUCT, 2023–2030 (USD MILLION)     519

TABLE 781            MEXICO: CELL CULTURE CONSUMABLES MARKET, BY TYPE,

2023–2030 (USD MILLION)            519

TABLE 782            MEXICO: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            520

TABLE 783            MEXICO: CELL CULTURE MEDIA MARKET, BY TYPE, 2023–2030 (USD MILLION)                520

TABLE 784            MEXICO: CELL CULTURE REAGENTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            521

TABLE 785            MEXICO: CELL CULTURE SERA MARKET, BY TYPE, 2023–2030 (USD MILLION)                521

TABLE 786            MEXICO: CELL CULTURE VESSELS MARKET, BY TYPE, 2023–2030 (USD MILLION)                522

TABLE 787            MEXICO: CELL CULTURE EQUIPMENT MARKET, BY TYPE,

2023–2030 (USD MILLION)            522

TABLE 788            MEXICO: CELL CULTURE MARKET FOR BIOREACTORS, BY TYPE,

2023–2030 (USD MILLION)            522

TABLE 789            MEXICO: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY TYPE,

2023–2030 (USD MILLION)          523

TABLE 790            MEXICO: CELL CULTURE MARKET FOR OTHER EQUIPMENT, BY TYPE,

2023–2030 (USD MILLION)            523

TABLE 791            MEXICO: CELL CULTURE MARKET, BY APPLICATION, 2023–2030 (USD MILLION)              524

TABLE 792            MEXICO: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION,

BY TYPE, 2023–2030 (USD MILLION)         524

TABLE 793            MEXICO: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2023–2030 (USD MILLION) 525

TABLE 794            MEXICO: CELL CULTURE MARKET, BY END USER, 2023–2030 (USD MILLION)                525

TABLE 795            REST OF LATIN AMERICA: CELL CULTURE MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            526

TABLE 796            REST OF LATIN AMERICA: CELL CULTURE CONSUMABLES MARKET,

BY TYPE, 2023–2030 (USD MILLION)         526

TABLE 797            REST OF LATIN AMERICA: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)            527

TABLE 798            REST OF LATIN AMERICA: CELL CULTURE MEDIA MARKET, BY TYPE,

2023–2030 (USD MILLION)            527

TABLE 799            REST OF LATIN AMERICA: CELL CULTURE REAGENTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            528

TABLE 800            REST OF LATIN AMERICA: CELL CULTURE SERA MARKET, BY TYPE,

2023–2030 (USD MILLION)            528

TABLE 801            REST OF LATIN AMERICA: CELL CULTURE VESSELS MARKET, BY TYPE,

2023–2030 (USD MILLION)            529

TABLE 802            REST OF LATIN AMERICA: CELL CULTURE EQUIPMENT MARKET, BY TYPE,

2023–2030 (USD MILLION)            529

TABLE 803            REST OF LATIN AMERICA: CELL CULTURE MARKET FOR BIOREACTORS, BY TYPE, 2023–2030 (USD MILLION)            530

TABLE 804            REST OF LATIN AMERICA: CELL CULTURE MARKET FOR STORAGE EQUIPMENT,

BY TYPE, 2023–2030 (USD MILLION)         530

TABLE 805            REST OF LATIN AMERICA: CELL CULTURE MARKET FOR OTHER EQUIPMENT,

BY TYPE, 2023–2030 (USD MILLION)         531

TABLE 806            REST OF LATIN AMERICA: CELL CULTURE MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            531

TABLE 807            REST OF LATIN AMERICA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2023–2030 (USD MILLION)            532

TABLE 808            REST OF LATIN AMERICA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2023–2030 (USD MILLION) 532

TABLE 809            REST OF LATIN AMERICA: CELL CULTURE MARKET, BY END USER,

2023–2030 (USD MILLION)            533

TABLE 810            MIDDLE EAST: CELL CULTURE MARKET, BY REGION, 2023–2030 (USD MILLION)          534

TABLE 811            MIDDLE EAST: CELL CULTURE MARKET, BY PRODUCT, 2023–2030 (USD MILLION)     534

TABLE 812            MIDDLE EAST: CELL CULTURE CONSUMABLES MARKET, BY TYPE,

2023–2030 (USD MILLION)            535

TABLE 813            MIDDLE EAST: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)                 535

TABLE 814            MIDDLE EAST: CELL CULTURE MEDIA MARKET, BY TYPE,

2023–2030 (USD MILLION)            536

TABLE 815            MIDDLE EAST: CELL CULTURE REAGENTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            536

TABLE 816            MIDDLE EAST: CELL CULTURE SERA MARKET, BY TYPE,

2023–2030 (USD MILLION)            537

TABLE 817            MIDDLE EAST: CELL CULTURE VESSELS MARKET, BY TYPE,

2023–2030 (USD MILLION)            537

TABLE 818            MIDDLE EAST: CELL CULTURE EQUIPMENT MARKET, BY TYPE,

2023–2030 (USD MILLION)            537

TABLE 819            MIDDLE EAST: CELL CULTURE MARKET FOR BIOREACTORS, BY TYPE,

2023–2030 (USD MILLION)            538

TABLE 820            MIDDLE EAST: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)                 538

TABLE 821            MIDDLE EAST: CELL CULTURE MARKET FOR OTHER EQUIPMENT, BY TYPE,

2023–2030 (USD MILLION)            539

TABLE 822            MIDDLE EAST: CELL CULTURE MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            539

TABLE 823            MIDDLE EAST: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2023–2030 (USD MILLION)            540

TABLE 824            MIDDLE EAST: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2023–2030 (USD MILLION)            540

TABLE 825            MIDDLE EAST: CELL CULTURE MARKET, BY END USER, 2023–2030 (USD MILLION)     541

TABLE 826            GCC COUNTRIES: CELL CULTURE MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            541

TABLE 827            GCC COUNTRIES: CELL CULTURE MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            542

TABLE 828            GCC COUNTRIES: CELL CULTURE CONSUMABLES MARKET, BY TYPE,

2023–2030 (USD MILLION)            542

TABLE 829            GCC COUNTRIES: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)                 542

TABLE 830            GCC COUNTRIES: CELL CULTURE MEDIA MARKET, BY TYPE,

2023–2030 (USD MILLION)            543

TABLE 831            GCC COUNTRIES: CELL CULTURE REAGENTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            543

TABLE 832            GCC COUNTRIES: CELL CULTURE SERA MARKET, BY TYPE,

2023–2030 (USD MILLION)            544

TABLE 833            GCC COUNTRIES: CELL CULTURE VESSELS MARKET, BY TYPE,

2023–2030 (USD MILLION)            544

TABLE 834            GCC COUNTRIES: CELL CULTURE EQUIPMENT MARKET, BY TYPE,

2023–2030 (USD MILLION)            544

TABLE 835            GCC COUNTRIES: CELL CULTURE MARKET FOR BIOREACTORS, BY TYPE,

2023–2030 (USD MILLION)            545

TABLE 836            GCC COUNTRIES: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)                 545

TABLE 837            GCC COUNTRIES: CELL CULTURE MARKET FOR OTHER EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)                 546

TABLE 838            GCC COUNTRIES: CELL CULTURE MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            546

TABLE 839            GCC COUNTRIES: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2023–2030 (USD MILLION)            547

TABLE 840            GCC COUNTRIES: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2023–2030 (USD MILLION)            547

TABLE 841            GCC COUNTRIES: CELL CULTURE MARKET, BY END USER,

2023–2030 (USD MILLION)            548

TABLE 842            SAUDI ARABIA: CELL CULTURE MARKET, BY PRODUCT, 2023–2030 (USD MILLION)     548

TABLE 843            SAUDI ARABIA: CELL CULTURE CONSUMABLES MARKET, BY TYPE,

2023–2030 (USD MILLION)            549

TABLE 844            SAUDI ARABIA: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)                 549

TABLE 845            SAUDI ARABIA: CELL CULTURE MEDIA MARKET, BY TYPE,

2023–2030 (USD MILLION)            550

TABLE 846            SAUDI ARABIA: CELL CULTURE REAGENTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            550

TABLE 847            SAUDI ARABIA: CELL CULTURE SERA MARKET, BY TYPE,

2023–2030 (USD MILLION)            551

TABLE 848            SAUDI ARABIA: CELL CULTURE VESSELS MARKET, BY TYPE,

2023–2030 (USD MILLION)            551

TABLE 849            SAUDI ARABIA: CELL CULTURE EQUIPMENT MARKET, BY TYPE,

2023–2030 (USD MILLION)            551

TABLE 850            SAUDI ARABIA: CELL CULTURE MARKET FOR BIOREACTORS, BY TYPE,

2023–2030 (USD MILLION)            552

TABLE 851            SAUDI ARABIA: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)                 552

TABLE 852            SAUDI ARABIA: CELL CULTURE MARKET FOR OTHER EQUIPMENT,

BY TYPE, 2023–2030 (USD MILLION)         553

TABLE 853            SAUDI ARABIA: CELL CULTURE MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            553

TABLE 854            SAUDI ARABIA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2023–2030 (USD MILLION)            554

TABLE 855            SAUDI ARABIA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2023–2030 (USD MILLION)            554

TABLE 856            SAUDI ARABIA: CELL CULTURE MARKET, BY END USER,

2023–2030 (USD MILLION)            555

TABLE 857            UAE: CELL CULTURE MARKET, BY PRODUCT, 2023–2030 (USD MILLION)            556

TABLE 858            UAE: CELL CULTURE CONSUMABLES MARKET, BY TYPE,

2023–2030 (USD MILLION)            556

TABLE 859            UAE: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET,

BY TYPE, 2023–2030 (USD MILLION)         556

TABLE 860            UAE: CELL CULTURE MEDIA MARKET, BY TYPE, 2023–2030 (USD MILLION)            557

TABLE 861            UAE: CELL CULTURE REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)                557

TABLE 862            UAE: CELL CULTURE SERA MARKET, BY TYPE, 2023–2030 (USD MILLION)            558

TABLE 863            UAE: CELL CULTURE VESSELS MARKET, BY TYPE, 2023–2030 (USD MILLION)                558

TABLE 864            UAE: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2023–2030 (USD MILLION)                558

TABLE 865            UAE: CELL CULTURE MARKET FOR BIOREACTORS, BY TYPE,

2023–2030 (USD MILLION)            559

TABLE 866            UAE: CELL CULTURE MARKET FOR STORAGE EQUIPMENT,

BY TYPE, 2023–2030 (USD MILLION)         559

TABLE 867            UAE: CELL CULTURE MARKET FOR OTHER EQUIPMENT, BY TYPE,

2023–2030 (USD MILLION)            560

TABLE 868            UAE: CELL CULTURE MARKET, BY APPLICATION, 2023–2030 (USD MILLION)              560

TABLE 869            UAE: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2023–2030 (USD MILLION)            561

TABLE 870            UAE: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2023–2030 (USD MILLION) 561

TABLE 871            UAE: CELL CULTURE MARKET, BY END USER, 2023–2030 (USD MILLION)            562

TABLE 872            REST OF GCC COUNTRIES: CELL CULTURE MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            563

TABLE 873            REST OF GCC COUNTRIES: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)                 563

TABLE 874          REST OF GCC COUNTRIES: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)            563

TABLE 875            REST OF GCC COUNTRIES: CELL CULTURE MEDIA MARKET, BY TYPE,

2023–2030 (USD MILLION)            564

TABLE 876            REST OF GCC COUNTRIES: CELL CULTURE REAGENTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            564

TABLE 877            REST OF GCC COUNTRIES: CELL CULTURE SERA MARKET, BY TYPE,

2023–2030 (USD MILLION)            565

TABLE 878            REST OF GCC COUNTRIES: CELL CULTURE VESSELS MARKET, BY TYPE,

2023–2030 (USD MILLION)            565

TABLE 879            REST OF GCC COUNTRIES: CELL CULTURE EQUIPMENT MARKET, BY TYPE,

2023–2030 (USD MILLION)            566

TABLE 880            REST OF GCC COUNTRIES: CELL CULTURE MARKET FOR BIOREACTORS, BY TYPE, 2023–2030 (USD MILLION)            566

TABLE 881            REST OF GCC COUNTRIES: CELL CULTURE MARKET FOR STORAGE EQUIPMENT,

BY TYPE, 2023–2030 (USD MILLION)         566

TABLE 882            REST OF GCC COUNTRIES: CELL CULTURE MARKET FOR OTHER EQUIPMENT,

BY TYPE, 2023–2030 (USD MILLION)         567

TABLE 883            REST OF GCC COUNTRIES: CELL CULTURE MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            567

TABLE 884            REST OF GCC COUNTRIES: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2023–2030 (USD MILLION)            568

TABLE 885            REST OF GCC COUNTRIES: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2023–2030 (USD MILLION) 568

TABLE 886            REST OF GCC COUNTRIES: CELL CULTURE MARKET, BY END USER,

2023–2030 (USD MILLION)            569

TABLE 887            REST OF MIDDLE EAST: CELL CULTURE MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            570

TABLE 888            REST OF MIDDLE EAST: CELL CULTURE CONSUMABLES MARKET, BY TYPE,

2023–2030 (USD MILLION)            570

TABLE 889            REST OF MIDDLE EAST: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET,

BY TYPE, 2023–2030 (USD MILLION)         570

TABLE 890            REST OF MIDDLE EAST: CELL CULTURE MEDIA MARKET, BY TYPE,

2023–2030 (USD MILLION)            571

TABLE 891            REST OF MIDDLE EAST: CELL CULTURE REAGENTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            571

TABLE 892            REST OF MIDDLE EAST: CELL CULTURE SERA MARKET, BY TYPE,

2023–2030 (USD MILLION)            572

TABLE 893            REST OF MIDDLE EAST: CELL CULTURE VESSELS MARKET, BY TYPE,

2023–2030 (USD MILLION)            572

TABLE 894            REST OF MIDDLE EAST: CELL CULTURE EQUIPMENT MARKET, BY TYPE,

2023–2030 (USD MILLION)            573

TABLE 895            REST OF MIDDLE EAST: CELL CULTURE MARKET FOR BIOREACTORS MARKET,

BY TYPE, 2023–2030 (USD MILLION)         573

TABLE 896            REST OF MIDDLE EAST: CELL CULTURE MARKET FOR STORAGE EQUIPMENT,

BY TYPE, 2023–2030 (USD MILLION)         573

TABLE 897            REST OF MIDDLE EAST: CELL CULTURE MARKET FOR OTHER EQUIPMENT,

BY TYPE, 2023–2030 (USD MILLION)         574

TABLE 898            REST OF MIDDLE EAST: CELL CULTURE MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            574

TABLE 899            REST OF MIDDLE EAST: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2023–2030 (USD MILLION)            575

TABLE 900            REST OF MIDDLE EAST: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2023–2030 (USD MILLION) 575

TABLE 901            REST OF MIDDLE EAST: CELL CULTURE MARKET, BY END USER,

2023–2030 (USD MILLION)            576

TABLE 902          AFRICA: CELL CULTURE MARKET, BY PRODUCT, 2023–2030 (USD MILLION)            577

TABLE 903            AFRICA: CELL CULTURE CONSUMABLES MARKET, BY TYPE,

2023–2030 (USD MILLION)            578

TABLE 904            AFRICA: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            578

TABLE 905            AFRICA: CELL CULTURE MEDIA MARKET, BY TYPE, 2023–2030 (USD MILLION)                578

TABLE 906            AFRICA: CELL CULTURE REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)         579

TABLE 907          AFRICA: CELL CULTURE SERA MARKET, BY TYPE, 2023–2030 (USD MILLION)            579

TABLE 908            AFRICA: CELL CULTURE VESSELS MARKET, BY TYPE, 2023–2030 (USD MILLION)                580

TABLE 909            AFRICA: CELL CULTURE EQUIPMENT MARKET, BY TYPE,

2023–2030 (USD MILLION)            580

TABLE 910            AFRICA: CELL CULTURE MARKET FOR BIOREACTORS, BY TYPE,

2023–2030 (USD MILLION)            580

TABLE 911            AFRICA: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY TYPE,

2023–2030 (USD MILLION)            581

TABLE 912            AFRICA: CELL CULTURE MARKET FOR OTHER EQUIPMENT, BY TYPE,

2023–2030 (USD MILLION)            581

TABLE 913            AFRICA: CELL CULTURE MARKET, BY APPLICATION, 2023–2030 (USD MILLION)              582

TABLE 914            AFRICA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION,

BY TYPE, 2023–2030 (USD MILLION)         582

TABLE 915            AFRICA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2023–2030 (USD MILLION) 583

TABLE 916            AFRICA: CELL CULTURE MARKET, BY END USER, 2023–2030 (USD MILLION)            583

TABLE 917            OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN CELL CULTURE MARKET, JANUARY 2022−JUNE 2025                 585

TABLE 918            CELL CULTURE MARKET: DEGREE OF COMPETITION 589

TABLE 919            CELL CULTURE MARKET: REGION FOOTPRINT                 596

TABLE 920            CELL CULTURE MARKET: PRODUCT FOOTPRINT       597

TABLE 921            CELL CULTURE MARKET: APPLICATION FOOTPRINT       598

TABLE 922            CELL CULTURE MARKET: END-USER FOOTPRINT       599

TABLE 923            CELL CULTURE MARKET: DETAILED LIST OF KEY STARTUPS/SMES    602

TABLE 924            CELL CULTURE MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES          603

TABLE 925          CELL CULTURE MARKET: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2025              604

TABLE 926            CELL CULTURE MARKET: DEALS, JANUARY 2021–JUNE 2025  605

TABLE 927            CELL CULTURE MARKET: EXPANSIONS, JANUARY 2021–JUNE 2025              607

TABLE 928            THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW          609

TABLE 929            THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED             611

TABLE 930            THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES,

JANUARY 2021–JUNE 2025              625

TABLE 931            THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2021–JUNE 2025              627

TABLE 932          THERMO FISHER SCIENTIFIC INC.: EXPANSIONS, JANUARY 2021–JUNE 2025              627

TABLE 933            DANAHER: COMPANY OVERVIEW            631

TABLE 934            DANAHER: PRODUCTS OFFERED             632

TABLE 935            DANAHER: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2025  643

TABLE 936            DANAHER: DEALS, JANUARY 2021–JUNE 2025                 644

TABLE 937            DANAHER CORPORATION: EXPANSIONS, JANUARY 2021–JUNE 2025              645

TABLE 938            DANAHER: OTHER DEVELOPMENTS, JANUARY 2021–JUNE 2025  647

TABLE 939            MERCK KGAA: COMPANY OVERVIEW     648

TABLE 940            MERCK KGAA: PRODUCTS OFFERED      649

TABLE 941            MERCK KGAA: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2025  656

TABLE 942            MERCK KGAA: DEALS, JANUARY 2021–JUNE 2025                 656

TABLE 943            MERCK KGAA: EXPANSIONS, JANUARY 2021–JUNE 2025             657

TABLE 944            SARTORIUS AG: COMPANY OVERVIEW  660

TABLE 945            SARTORIUS AG: PRODUCTS OFFERED   661

TABLE 946            SARTORIUS AG: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2025              669

TABLE 947            SARTORIUS AG.: DEALS, JANUARY 2021–JUNE 2025        669

TABLE 948            SARTORIUS AG: EXPANSIONS, JANUARY 2021–JUNE 2025             672

TABLE 949            CORNING INCORPORATED: COMPANY OVERVIEW          673

TABLE 950            CORNING INCORPORATED: PRODUCTS OFFERED             674

TABLE 951            CORNING INCORPORATED: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2025     684

TABLE 952            CORNING INCORPORATED: DEALS, JANUARY 2021–JUNE 2025  685

TABLE 953            FUJIFILM HOLDINGS CORPORATION: COMPANY OVERVIEW   686

TABLE 954            FUJIFILM HOLDINGS CORPORATION: PRODUCTS OFFERED    687

TABLE 955            FUJIFILM HOLDINGS CORPORATION: PRODUCT LAUNCHES,

JANUARY 2021–JUNE 2025              694

TABLE 956            FUJIFILM HOLDINGS CORPORATION: DEALS, JANUARY 2021–JUNE 2025              694

TABLE 957            FUJIFILM HOLDINGS CORPORATION: EXPANSIONS, JANUARY 2021–JUNE 2025 695

TABLE 958            FUJIFILM HOLDINGS CORPORATION: OTHER DEVELOPMENTS,

JANUARY 2021–JUNE 2025              696

TABLE 959            BD: COMPANY OVERVIEW           697

TABLE 960            BD: PRODUCTS OFFERED            698

TABLE 961            BD: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2025        700

TABLE 962            BD: DEALS, JANUARY 2021–JUNE 2025      701

TABLE 963            EPPENDORF SE: COMPANY OVERVIEW 702

TABLE 964            EPPENDORF SE: PRODUCTS OFFERED  703

TABLE 965            EPPENDORF SE: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2025              708

TABLE 966            EPPENDORF SE: DEALS, JANUARY 2021–JUNE 2025        709

TABLE 967            EPPENDORF SE: EXPANSIONS, JANUARY 2021–JUNE 2025             709

TABLE 968            LONZA: COMPANY OVERVIEW  711

TABLE 969            LONZA: PRODUCTS OFFERED   712

TABLE 970            LONZA: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2025             715

TABLE 971            LONZA: DEALS, JANUARY 2021–JUNE 2025                 716

TABLE 972            GETINGE: COMPANY OVERVIEW              717

TABLE 973            GETINGE: PRODUCTS OFFERED               718

TABLE 974            GETINGE: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2025  719

TABLE 975            GETINGE: DEALS, JANUARY 2021–JUNE 2025                 720

TABLE 976            GETINGE: EXPANSIONS, JANUARY 2021–JUNE 2025        721

TABLE 977            AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW          722

TABLE 978            AGILENT TECHNOLOGIES, INC.: PRODUCTS OFFERED             723

TABLE 979            AGILENT TECHNOLOGIES, INC.: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2025     725

TABLE 980            AGILENT TECHNOLOGIES, INC.: DEALS, JANUARY 2021–JUNE 2025              726

TABLE 981            AGILENT TECHNOLOGIES, INC.: EXPANSIONS, JANUARY 2021–JUNE 2025              726

TABLE 982            HIMEDIA LABORATORIES: COMPANY OVERVIEW          727

TABLE 983            HIMEDIA LABORATORIES: PRODUCTS OFFERED             727

TABLE 984            BIO-TECHNE: COMPANY OVERVIEW      731

TABLE 985            BIO-TECHNE: PRODUCTS OFFERED       732

TABLE 986            BIO-TECHNE: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2025  736

TABLE 987            BIO-TECHNE: DEALS, JANUARY 2021–JUNE 2025                 736

TABLE 988            BIO-TECHNE: EXPANSIONS, JANUARY 2021–JUNE 2025             737

TABLE 989            MILTENYI BIOTEC: COMPANY OVERVIEW                 738

TABLE 990            STEMCELL TECHNOLOGIES: COMPANY OVERVIEW          740

TABLE 991            SOLIDA BIOTECH GMBH: COMPANY OVERVIEW                 743

TABLE 992            CAISSON LABS: COMPANY OVERVIEW   744

TABLE 993            PROMOCELL GMBH: COMPANY OVERVIEW                 745

TABLE 994            INVIVOGEN: COMPANY OVERVIEW         746

TABLE 995            PAN-BIOTECH: COMPANY OVERVIEW   747

TABLE 996            CELLEXUS: COMPANY OVERVIEW            748

TABLE 997            MEISSNER FILTRATION PRODUCTS, INC.: COMPANY OVERVIEW   749

TABLE 998            ADOLF KÜHNER AG: COMPANY OVERVIEW                 751

TABLE 999            ADVANCION CORPORATION: COMPANY OVERVIEW          752

TABLE 1000         BIOSPHERIX LLC: COMPANY OVERVIEW                 753

LIST OF FIGURES

FIGURE 1              CELL CULTURE MARKET SEGMENTATION                 60

FIGURE 2              REGIONAL SCOPE            61

FIGURE 3              CELL CULTURE MARKET: RESEARCH DESIGN                 64

FIGURE 4              CELL CULTURE MARKET: BREAKDOWN OF PRIMARY INTERVIEWS  66

FIGURE 5              CELL CULTURE MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2024  67

FIGURE 6              MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE

ANALYSIS-BASED ESTIMATION), 2024     68

FIGURE 7              ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC INC.:

REVENUE SHARE ANALYSIS, 2024               68

FIGURE 8              MARKET SIZE VALIDATION FROM PRIMARY SOURCES             70

FIGURE 9              SEGMENTAL MARKET SIZE ESTIMATION: TOP-DOWN APPROACH          70

FIGURE 10            CELL CULTURE MARKET: CAGR PROJECTIONS (2025-2030)           72

FIGURE 11            DATA TRIANGULATION METHODOLOGY                 74

FIGURE 12            CELL CULTURE MARKET, BY PRODUCT, 2025 VS. 2030 (USD MILLION)       77

FIGURE 13            CELL CULTURE MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION)      78

FIGURE 14            CELL CULTURE MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)       78

FIGURE 15            GEOGRAPHICAL SNAPSHOT OF CELL CULTURE MARKET               79

FIGURE 16            GROWING POPULARITY OF MONOCLONAL ANTIBODIES AND

BIOSIMILARS TO DRIVE MARKET              80

FIGURE 17            CONSUMABLES SEGMENT AND US LED NORTH AMERICAN MARKET IN 2024        81

FIGURE 18            BIOPHARMACEUTICAL PRODUCTION SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2024                 81

FIGURE 19            PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES SEGMENT

DOMINATED END-USER MARKET IN 2024             82

FIGURE 20            ASIA PACIFIC COUNTRIES TO REGISTER HIGHER GROWTH

DURING FORECAST PERIOD       82

FIGURE 21            CELL CULTURE MARKET: DRIVERS, RESTRAINTS,

OPPORTUNITIES, AND CHALLENGES     83

FIGURE 22            NUMBER OF ANTIBODY THERAPEUTICS GRANTED FIRST

APPROVAL IN US/EU, 2012−2024               90

FIGURE 23            NUMBER OF BIOSIMILARS APPROVED AND LAUNCHED, 2015−2024 91

FIGURE 24            CLINICAL TRIAL OVERVIEW OF TISSUE-ENGINEERED PRODUCTS, 2019–2023       93

FIGURE 25            GLOBAL HIV EPIDEMIC, 2023      95

FIGURE 26            NEW REVENUE POCKETS FOR PLAYERS IN CELL CULTURE MARKET          103

FIGURE 27            AVERAGE SELLING PRICE TREND OF CELL-BASED ASSAY PRODUCTS, 2022–2024       104

FIGURE 28            CELL CULTURE MARKET: VALUE CHAIN ANALYSIS            106

FIGURE 29            CELL CULTURE MARKET: ECOSYSTEM ANALYSIS            108

FIGURE 30            CELL CULTURE MARKET: INVESTMENT AND FUNDING SCENARIO, 2020–2024 110

FIGURE 31            CELL CULTURE MARKET: PATENT ANALYSIS, 2014–2024              116

FIGURE 32            CELL CULTURE MARKET: PORTER’S FIVE FORCES ANALYSIS           131

FIGURE 33            INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF

CELL CULTURE PRODUCTS        133

FIGURE 34            KEY BUYING CRITERIA, BY END USER    134

FIGURE 35            AI USE CASES     136

FIGURE 36            NORTH AMERICA: CELL CULTURE MARKET SNAPSHOT          380

FIGURE 37            ASIA PACIFIC: CELL CULTURE MARKET SNAPSHOT          454

FIGURE 38            REVENUE ANALYSIS OF KEY PLAYERS IN CELL CULTURE MARKET,

2020–2024 (USD BILLION)             587

FIGURE 39            MARKET SHARE ANALYSIS OF KEY PLAYERS IN CELL CULTURE MARKET, 2024   588

FIGURE 40            EV/EBITDA OF KEY VENDORS   590

FIGURE 41            YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK

BETA OF KEY VENDORS                591

FIGURE 42            CELL CULTURE MARKET: BRAND/PRODUCT COMPARISON   592

FIGURE 43            CELL CULTURE MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024         594

FIGURE 44            CELL CULTURE MARKET: COMPANY FOOTPRINT       595

FIGURE 45            CELL CULTURE MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 601

FIGURE 46            THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2024)             610

FIGURE 47            DANAHER: COMPANY SNAPSHOT (2024)                 632

FIGURE 48            MERCK KGAA: COMPANY SNAPSHOT (2024)                 649

FIGURE 49            SARTORIUS AG: COMPANY SNAPSHOT (2024)                 661

FIGURE 50            CORNING INCORPORATED: COMPANY SNAPSHOT (2024)             674

FIGURE 51            FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT (2024)      687

FIGURE 52            BD: COMPANY SNAPSHOT (2024)              698

FIGURE 53            EPPENDORF SE: COMPANY SNAPSHOT (2024)                 703

FIGURE 54            LONZA: COMPANY SNAPSHOT (2024)     712

FIGURE 55            GETINGE: COMPANY SNAPSHOT (2024) 718

FIGURE 56            AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2024)             723

FIGURE 57            BIO-TECHNE: COMPANY SNAPSHOT (2024)                 732

MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。

※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。

ライセンス別価格表

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

ライセンスタイプ1

ライセンスタイプ2

ライセンスタイプ3

ライセンスタイプ4

ミニレポート　※定性調査にフォーカスした調査レポートです。詳細はお問合せください。

ご購入に関するご案内

価格・納期について

• 価格
  • ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス
    • 1名のみレポートファイルのご利用が可能です。
  • マルチユーザライセンス
    • 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
  • コーポレートライセンス
    • 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
  • エンタープライズサイトライセンス
    • 特別ライセンスです。適用範囲についてはお問合せください。
• 納品形態
  • Eメール
• 納期
  • 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。

最新調査レポート

• 自動車用アラミド繊維市場規模、シェア、動向、2030年までの世界予測 2025-12-15
• ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測 2025-12-15
• 複合輸送市場規模、シェア、動向、2032年までの世界予測 2025-12-12
• 有機酸市場規模、シェア、動向、2030年までの世界予測 2025-12-11
• ハイブリッドボンディング市場規模、シェア、動向、2032年までの世界予測 2025-12-11

MarketsandMarkets  出版レポート一覧